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Methylation of cytosines in themammalian genome represents a key epigenetic modification and is
dynamically regulated during development. Compelling evidence now suggests that dynamic regu-
lation of DNA methylation is mainly achieved through a cyclic enzymatic cascade comprised of
cytosine methylation, iterative oxidation of methyl group by TET dioxygenases, and restoration
of unmodified cytosines by either replication-dependent dilution or DNA glycosylase-initiated
base excision repair. In this review, we discuss the mechanism and function of DNA demethylation
in mammalian genomes, focusing particularly on how developmental modulation of the cytosine-
modifying pathway is coupled to active reversal of DNAmethylation in diverse biological processes.Introduction
It has long been recognized that cytosines in the genome, as part
of the genetic code, also carry epigenetic information through
chemical modification of its pyrimidine ring (Holliday and Pugh,
1975; Riggs, 1975). The dual functions associated with cytosines
provide a means by which developmental stage- and cell-type-
specific epigenetic memory can be directly deposited onto
DNA itself (Bird, 2002). Methylation of the fifth position of cyto-
sine (5-methylcytosine, 5mC) is a highly conserved epigenetic
modification of DNA found in most plant, animal and fungal
models (Law and Jacobsen, 2010) and has a profound impact
on genome stability, gene expression, and development (Jae-
nisch and Bird, 2003; Smith and Meissner, 2013).
In mammals, new DNA methylation pattern is established by
de novo DNA methyltransferases, DNMT3A and DNMT3B
(Okano et al., 1999; Okano et al., 1998) (Figures 1A and 1B). Their
activity can be modulated by a catalytically inactive family mem-
ber, DNMT3L (Goll and Bestor, 2005). In somatic cells, 5mC is
primarily restricted to palindromic CpG dinucleotides, which
are typically methylated in a symmetric manner (de novo methyl-
ation in Figure 2A). Methylation of cytosine in non-CpG context
(CpH, H = A, T, C) is prevalent in plants (Law and Jacobsen,
2010) but is rare in most mammalian cell-types. Recent work
suggests that non-CpG methylation is relatively abundant in
oocytes, pluripotent embryonic stem cells (ESCs), and mature
neurons (Lister et al., 2013; Lister et al., 2009; Shirane et al.,
2013; Xie et al., 2012), but the function of mammalian non-CpG
methylation remains unclear. Of the roughly 28 million CpGs in
the human genome, 60%–80% are methylated in somatic cells
(Smith and Meissner, 2013). During mitosis, the global CpGmethylation pattern is faithfully maintained in daughter cells
through the action of maintenance DNA methyltransferase
DNMT1 and its obligate partner, the ubiquitin-like plant homeo-
domain and RING finger domain 1 (UHRF1), which preferentially
recognizes hemimethylated CpGs (Bostick et al., 2007; Hermann
et al., 2004; Sharif et al., 2007) (maintenance methylation in Fig-
ures 1A and 2A). Such inheritability of CpGmethylation suggests
a role for 5mC in long-term epigenetic regulation required for
diverse biological processes, such as stable silencing of gene
expression, maintenance of genome stability, and establishment
of genomic imprinting (Bird, 2002).
Although DNA methylation pattern in somatic cells is stably
maintained, genome-wide loss of 5mC, or DNA demethylation,
has been observed in specific developmental stages such as
preimplantation embryos and developing primordial germ cells
(PGCs) (Hajkova et al., 2002; Mayer et al., 2000; Oswald et al.,
2000; Sasaki and Matsui, 2008). Global DNA demethylation is
important for setting up pluripotent states in early embryos and
for erasing parental-origin-specific imprints in developing
PGCs (Feng et al., 2010b). Mounting evidence indicates that
the rapid erasure of 5mC during these twomajor waves of epige-
netic reprogramming could not be fully explained by replication-
dependent passive loss of 5mC, suggesting the existence of
enzymatic activities capable of actively removing or modifying
methyl groups on cytosines (Wu and Zhang, 2010). However, a
unifying mechanistic understanding of active DNA demethyla-
tion processes in mammalian cells did not emerge until recently.
As we will discuss below, the transformative discovery of ten-
eleven translocation (TET) proteins as 5mCoxidase has provided
major insights into mechanisms of active DNA demethylation.Cell 156, January 16, 2014 ª2014 Elsevier Inc. 45
Figure 1. Domain Architecture and Enzy-
matic Activities of Cytosine Methylation
and Demethylation Machineries
(A) Schematic diagrams of predicted functional
domains in proteins involved in de novo methyl-
ation, maintenance methylation, 5mC oxidation,
and 5fC/5caC excision. All TET proteins contain a
C-terminal catalytic domain that includes a Cys-
rich insert and a large double-stranded b-helix
(DSBH) domain. TET1 and TET3 proteins also
contain a N-terminal CXXC domain. TDG contains
a uracil DNA glycosylase (UDG) domain. The
number of amino acids of the full-length isoform is
indicated, and the numbering corresponds to
mouse proteins. ADD, ATRX-DNMT3-DNMT3L;
PWWP, proline-tryptophan-tryptophan-proline
motif; MTase, DNA methyltransferase domain;
BAH, bromo-adjacent homology; CXXC, zinc-
finger Cystien-X-X-Cystine; SRA, SET and RING
associated; RING, Really interesting new gene;
PHD, Plant homeodomain; UBL, ubiquitin-like
domain.
(B) The step-wise cytosine modification pathway
that includes cytosine methylation by DNMTs and
iterative oxidation of 5mC by TET proteins.
DNMTs use S-adenosylmethionine (SAM) as a
methyl donor to catalyze methylation at the
5-position of cytosine, yielding S-ad-
enosylhomocysteine (SAH). As Fe(II)/a-ketoglu-
tarate (a-KG)-dependent dioxygenases, TET
proteins use a base-flipping mechanism to flip
the target base out of the duplex DNA into the
catalytic site (Hashimoto et al., 2013; Hu et al.,
2013). The active site Fe(II) is bound by
conserved His-His-Asp residues in TETs and
coordinates water and a-KG. TET enzymes use
molecular oxygen as a substrate to catalyze
oxidative decarboxylation of a-KG, yielding CO2,
enzyme-bound succinate, and a reactive high-
valent Fe(IV)-oxo intermediate. The enzyme-
bound Fe(IV)-oxo intermediate reacts with 5mC/
5hmC/5fC to generate 5hmC/5fC/5caC, with a
net oxidative transfer of the single oxygen atom to the substrate, resulting in regeneration of the Fe(II) species.
(C) Base excision repair of 5mC (in plants) or 5fC/5caC (in mammals) to complete DNA demethylation. In plants, the DME/ROS1 family of bifunctional DNA
glycosylases is capable of catalyzing the release of 5mC base from DNA by cleavage of the N-glycosidic bond, generating an abasic (apurinic and apyrimidinic
[AP]) site. The DNA backbone is then nicked by AP lyase activity of DME/ROS1 enzymes. The 30 sugar group is then cleaved by an AP endonuclease and the
resulting single-nucleotide gap is filled in with an unmodified C by DNA polymerase and ligase activities. In mammals, oxidized 5mC bases (5fC/5caC), could be
excised by TDG. TDG is a monofunctional DNA glycosylase, so other proteins are required to provide the AP lyase activity to remove the sugar ring to generate a
single-nucleotide gap.The biochemical basis of TET enzymes in oxidative modification
of 5mC has recently been reviewed elsewhere (Kohli and Zhang,
2013; Pastor et al., 2013). In this review, we focus on an inte-
grated understanding of mechanisms, genomics, and biological
functions of mammalian DNA demethylation process. First, we
summarize the current mechanistic understanding of passive
and active DNA demethylation pathways. Second, we examine
the recent advances in development of genomic mapping tech-
nologies for 5mC oxidation derivatives as well as the under-
standing of potential regulatory functions of oxidized cytosine
bases in the mammalian genome. Finally, we discuss how
distinct modes of DNA demethylation dynamics can be achieved
through modulation of the cytosine-modifying enzymatic
pathway to satisfy the needs of diverse biological processes.
DNA Methylation and Demethylation in Mammals: A
Cyclic Enzymatic Cascade
DNA demethylation can take place either passively or actively.
Upon DNA replication, the maintenance machinery DNMT1/46 Cell 156, January 16, 2014 ª2014 Elsevier Inc.UHRF1 restores the symmetrical CpG methylation pattern by
methylating the unmodified cytosine in the nascent DNA strand
(Bostick et al., 2007; Sharif et al., 2007). Passive loss of 5mC
can therefore be achieved through successive cycles of DNA
replication in the absence of functional DNMT1/UHRF1 (passive
dilution of 5mC [PD] in Figure 2A). One example of replication-
dependent passive loss of 5mC is the global erasure of 5mC in
the maternal genome during mouse preimplantation develop-
ment (see below).
Compelling evidence indicates that 5mC can also be rapidly
erased independently of DNA replication in specific biological
settings in both plants and mammals (Law and Jacobsen,
2010; Wu and Zhang, 2010). Such change involves active DNA
demethylation mechanisms, which require one or more enzy-
matic reactions to modify or remove 5mC. In flowing plants
(e.g., Arabidopsis thaliana), active erasure of 5mC is mediated
by the Demeter (DME)/repressor of silencing 1 (ROS1) family of
DNA glycosylases and base excision repair (BER) machinery
(Zhu, 2009) (Figure 1C). However, mammalian orthologs of
Figure 2. Mechanisms of Passive and
Active Reversal of CpG DNA Methylation
(A) Schematic diagrams of replication-dependent
passive loss of 5mC or oxidized 5mC within CpG
dyads. Replication-dependent passive dilution
(PD) of 5mC occurs in the absence of the DNA
methylation maintenance machinery (DNMT1/
UHRF1). By contrast, 5mC oxidation derivatives,
5hmC (h) (potentially 5fC [f] and 5caC [ca]) may
facilitate passive demethylation as hemihy-
droxymethylated CpGs is an inefficient substrate
for DNMT1. This form of active DNA demethylation
is termed as active modification (AM) followed by
passive dilution (AM-PD). Whether DNMT1 or
DNMT3 can efficiently methylate CpG dyads
hemimodified with 5fC/5caC is unclear.
(B) Schematic diagrams of replication-indepen-
dent DNA demethylation within CpG dyads. TET
and TDG mediate sequential 5mC oxidation and
5fC/5caC excision. The resulting abasic site is
repaired by BER to regenerate unmodified cyto-
sines. All possible intermediate products (a total of
21 distinct cytosine modification states for a single
CpG dyad) of the DNMT/TET/TDG/BER enzymatic
cascade are depicted. For each state, the left half
represents the top strand of CpG dyad, whereas
the right half indicates the bottom strand. The
arrows represent enzymatic reactions and are
color-coded according to that of the correspond-
ing enzyme. One of many potential combinations
of intermediate steps for the TET/TDG-mediated
active DNA demethylation process is highlighted
in gray. Of note, 5fC can be directly excised by
TDG to generate abasic site (e.g., f:ca/ ab:ab).
For clarity, all f/ ab reactions are not depicted.DME/ROS1 enzymes have not been identified. Mammalian cells
may therefore achieve active DNA demethylation using different
mechanisms. Early efforts focused on testing various known
DNA modifying proteins, such as DNA repair enzymes, cytosine
deaminases, and DNA glycosylases (Box 1A). However, experi-
mental evidence for these proposed candidates is often
restricted to very specific biological settings, and in many cases
the activity cannot be substantiated by follow-up studies (Ooi
and Bestor, 2008; Wu and Zhang, 2010). Thus, these studies
did not reveal a consensus mechanistic framework for active
DNA demethylation in mammals.
The breakthrough came in 2009 when the presence of 5-
hydroxymethylcytosine (5hmC), an oxidized derivative of
5mC, was unambiguously demonstrated in the mammalian
genome and TET family of DNA dioxygenases were identified
as the enzyme that convert 5mC to 5hmC (Kriaucionis and
Heintz, 2009; Tahiliani et al., 2009). Subsequent studies have
revealed that TET proteins can further oxidize 5hmC to 5-for-
mylcytosine (5fC) and 5-carboxycytosine (5caC) (He et al.,
2011; Ito et al., 2011; Pfaffeneder et al., 2011). This series of
discoveries have established the biochemical basis for under-
standing the molecular mechanism of active DNA demethyla-
tion in mammals.Cell 15Iterative Oxidation of 5mC by TET
Proteins
The discovery of enzymatic activity modi-
fying 5mC through oxidation was moti-vated by two known pathways involved in oxidative modification
of thymine (T). The first involves the biosynthesis of ‘‘base J’’
(b-D-glucosyl-hydroxymethyluracil), a modified base present
in the genome of the parasite Trypanosome brucei that
causes African sleeping sickness (Borst and Sabatini, 2008).
Base J biosynthesis is achieved by a two-step process. J-bind-
ing protein (JBP) 1 and 2 first oxidize T in the DNA to 5-hydrox-
ymethyluracil (5hmU); then a glycosyltransferase completes
the synthesis of base J by adding glucose groups to 5hmU (Borst
and Sabatini, 2008). JBP1/2 proteins are members of the Fe(II)/
a-ketoglutarate (a-KG)-dependent dioxygenase family (Loenarz
and Schofield, 2011). Systematic bioinformatic analysis identi-
fied the human gene, TET1, as a homolog of JBP1/2 (Iyer
et al., 2009). TET1, initially discovered as a fusion partner of
the histone H3 Lys4 methyltransferase mixed-lineage leukemia
1 (MLL1) (t(10;11)(q22;q23)) in certain acute myeloid leukemia
(AML) (Lorsbach et al., 2003; Ono et al., 2002), contains a
C-terminal catalytic domain consisting of a Cys-rich region and
a double-stranded b-helix (DSBH) fold (Figure 1A). Overexpres-
sion of TET1 in cultured cells results in reduction of genomic
5mC level, and recombinant TET1 proteins can oxidize 5mC
in vitro and the resulting product was determined as 5hmC
(Tahiliani et al., 2009) (Figure 1B). Similar enzymatic activity6, January 16, 2014 ª2014 Elsevier Inc. 47
Box 1. Known and Putative Mechanisms of Active Erasure of
5-Methylcytosines
A. 5mC Oxidation-Independent Active DNA Demethylation Mecha-
nisms
1. Enzymatic Removal of the Methyl Group from 5mC
The most straightforward way to achieve DNA demethylation is
direct removal of the methyl-group. However, this is a thermo-
dynamically unfavorable reaction. One study proposed that
methyl-CpG-binding domain protein 2 (MBD2) can catalyze such
a reaction leading to the release of methanol, but other labora-
tories could not reproduce this finding and active erasure of
paternal 5mC occurs normally in fertilized oocytes lacking Mbd2
(Wu and Zhang, 2010). To date, no compelling evidence supports
that this biochemical reaction could take place under physiolog-
ical conditions.
2. Nucleotide Excision Repair to Erase 5mC
Excision repair of short genomic regions that contain methylated
cytosine nucleotides can indirectly result in erasure of 5mC. There
are two major DNA excision repair mechanisms to repair single-
stranded DNA damage: base excision repair (BER) and nucleotide
excision repair (NER). BER is used to correct damaged bases or
mismatched base pairs (e.g., G:T mismatch), whereas NER can
repair bulky DNA lesions formed by exposure to radiation or
chemicals. Once the bulky DNA lesion is recognized, specific
enzymatic activities introduce dual incisions flanking the damage
region. The resulting single-stranded gap (usually 24–32 nucleo-
tides) is then filled in by DNA repair polymerases and ligases. The
Gadd45 (growth arrest and DNA-damage-inducible protein 45)
family of proteins was reported to stimulate active DNA deme-
thylation via NER (Barreto et al., 2007). While some evidence
suggests that Gadd45 may induce active DNA demethylation in
Xenopus laevis embryos andmammalian cells (Ma et al., 2009; Rai
et al., 2008; Schmitz et al., 2009), conflicting results were also
reported (Jin et al., 2008). Furthermore, Gadd45a- and Gadd45b
null mice are grossly normal and have no global alteration in DNA
methylation levels (Engel et al., 2009; Ma et al., 2009). Thus, the
role of Gadd45 in DNA demethylation remains uncertain.
3. Direct Base Excision Repair of 5mC by DNA Glycosylases
Active DNA demethylation can be achieved by a DNA glycosylase
that efficiently excises 5mC base from DNA. Strong genetic and
biochemical evidence supports the use of this mechanism in
plants (Zhu, 2009). Mammalian DNA glycosylases, including TDG
and methyl-CpG binding domain-containing protein 4 (MBD4),
were also proposed to have excision activity against 5mC (Zhu
et al., 2000). However, 5mC excision activity of these enzymes is
significantly (30- to 40-fold) lower than their activity for T or U in
T,G or U,G mismatches. In addition, Mbd4 null mice are viable
and have normal DNA methylation pattern during development.
Interestingly, Tdg null mice die around E12.5 and exhibit modest
increase in level of 5mC at some CpG-rich gene promoters
(Corta´zar et al., 2011; Cortellino et al., 2011). Because TDG, but
not MBD4, has robust activity toward 5fC and 5caC, it is likely that
5fC/5caC excision activity, instead of the marginal 5mC excision
activity of TDG, is responsible for methylation defects observed in
Tdg-deficient cells (see main text).
4. Deamination and Repair of 5mC Base
Deamination of 5mC generates thymine and the resulting G,T
mismatch can be repaired by multiple DNA glycosylases (e.g.,
TDG) and BER to replace the mismatched T with C. Activation-
induced deaminase (AID)/APOBEC-family of cytidine deaminases
are known to function in generating mutations in DNA and RNA,
which are biologically important for antibody diversification in
B cells and for RNA editing (Conticello, 2008). In vitro biochemical
analysis suggests that AID/APOBEC could also deaminate 5mC
to T (Morgan et al., 2004). However, AID/APOBEC only efficiently
acts on single-strand but not double-strand DNA (Bransteitter
et al., 2003), and exhibit substantially lower activity on 5mC (10- to
20-fold) relative to cytosine, their canonical substrate (Nabel et al.,
2012). In addition, AID- or APOBEC1-knockout mice exhibit the
expected B cell and immunological defects, but are viable and
fertile (Wu and Zhang, 2010). Nevertheless, studies in zebrafish
embryos (Rai et al., 2008), mouse PGCs (Popp et al., 2010), mouse
ESC/human fibroblast fused heterokaryons (Bhutani et al., 2010),
and iPSCs (Kumar et al., 2013), support a potential role of AID/
APOBEC-mediated 5mC deamination in DNA demethylation.
Further studies are needed to clarify the exact biochemical
mechanism and function of AID/APOBEC proteins in DNA de-
methylation. Moreover, de novo DNMTs have been reported to
possess in vitro 5mC deaminase activity in the absence of the
methyl-donor S-adenosylmethionine (SAM) (Me´tivier et al., 2008).
Given that SAM is relatively abundant in all living cells and is a
general methyl-group donor for many essential enzymes, the
in vivo relevance of DNMT-mediated deamination of 5mC remains
unknown (Ooi and Bestor, 2008).
5. Radical SAM Mechanisms
Elongator complex protein 3 (ELP3) was reported to promote
paternal genome demethylation in mouse zygotes (Okada et al.,
2010). While it is proposed that the Fe-S radical SAM domain of
ELP3 may be involved in the demethylation process (Wu and
Zhang, 2010), direct biochemical evidence demonstrating the
demethylation activity of ELP3 is currently lacking.
B. 5mC Oxidation-Dependent Active DNA Demethylation
Mechanisms
1. Replication-Dependent Passive Dilution of Oxidized 5mC
Iterative oxidation of 5mC by TET proteins generates oxidized
cytosine bases (5hmC/5fC/5caC). These cytosine analogs may
facilitate DNA demethylation by impairing the binding and/or
activity of maintenance methylation machinery (DNMT1/UHRF1)
during DNA replication. Compelling evidence suggests that this
mechanism is used in the erasure of paternal genomemethylation
during preimplantation development as well as in the complete
demethylation of imprinting control regions in developing PGCs
(see main text).
2. DNA Repair-Mediated Excision of Modified 5mC
TDG-mediated excision of 5fC/5caC followed by BER. TET
proteins further oxidize 5hmC to 5fC and 5caC, which can be
efficiently excised by TDG and repaired by BER pathway. Multiple
studies have biochemically validated this pathway (see main text).
Compelling genetic and genomic evidence suggests that TET/
TDG-mediated active DNA demethylation takes place in mouse
ESCs, but how extensive this mechanism is utilized in vivo and in
other cell-types is currently unknown.
AID/APOBEC-mediated deamination of 5hmC followed by BER.
Similar to 5mC deamination, AID/APOBEC proteins may theo-
retically deaminate 5hmC to generate 5-hydroxyuracil (5hmU).
One study has shown that 5hmC deamination by AID/APOBEC
may take place in cultured cells and in mouse brain (Guo et al.,
2011). The resulting 5hmU,G mismatch can be repaired by DNA
glycosylases such as TDG and SMUG1 (Cortellino et al., 2011).
However, subsequent studies show that AID/APOBEC proteins
exhibit no detectable deaminase activity against 5hmC in in vitro
Box 1. Continued
(Continued on next page)
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Box 1. Continued
biochemical assays or in cells overexpressing these enzymes
(Nabel et al., 2012), challenging the biochemical plausibility of this
proposedmechanism. One potential explanation for the negligible
activity of AID/APOBEC on 5hmC is that the relatively bulky steric
size of 5-position substituent (cytosine [H] < 5mC [CH3 ] < 5hmC
[OHCH2 ]) may have a significant negative impact on deaminase
activity (Nabel et al., 2012).
3. Direct Removal of the Oxidized 5-Position Substitute
Dehydroxymethylation by DNMTs. Although direct removal of a
methyl group from 5mC is thermodynamically challenging, the
removal of the oxidized methyl group is more feasible. In vitro
biochemical studies suggest that DNMT3A/3B can remove the
hydroxymethyl group of 5hmC to generate unmodified cytosine in
the absence of SAM and under oxidizing conditions (Chen et al.,
2012; Liutkeviciute et al., 2009). Given that SAM is present at
relatively high levels in in all cell types, the physiological relevance
of this reaction remains unclear.
Decarboxylation of 5caC. In the thymine salvage pathway, T-to-U
conversion is completed by iso-orotate decarboxylase-mediated
decarboxylation of 5-carboxyuracil (Smiley et al., 2005). Given the
chemical similarity between THase and TET enzymes, it has been
proposed that decarboxylation activity may exist in mammalian
cells to directly convert 5caC to unmodified cytosine (Wu and
Zhang, 2010). One study suggests that 5caC decarboxylase
activity may exist in mouse ESC lysates (Schiesser et al., 2012),
but the responsible enzyme awaits to be identified.was also demonstrated in all three TET proteins in mouse
(TET1-3) (Ito et al., 2010). Supporting the physiological relevance
of TET-mediated 5mC oxidation, 5hmC can be readily detected
in most cell-types (1%–5% of 5mC) and is particularly enriched
in the genome of adult neurons (15%–40% of 5mC) (Globisch
et al., 2010; Kriaucionis and Heintz, 2009).
The second pathway that provides clues on enzymatic activ-
ity of TET proteins involves T-to-uracil (U) conversion in the
pyrimidine salvage pathway. In this process, T is first converted
by thymine hydroxylase (THase), also a Fe(II)/a-KG-dependent
dioxygenase, to 5hmU, 5-formyluracil (5fU), and 5-carboxylura-
cil (5caU) through three successive oxidation reactions; then
isoorotate decarboxylase completes the T-to-U conversion
through decarboxylation of 5caU (Smiley et al., 2005). The
similarity in chemistry between T-to-U conversion and oxidative
modification of 5mC suggests the possibility that TET enzymes
may function similarly to THase and can mediate iterative
oxidation of 5mC (Wu and Zhang, 2010). With improved chro-
matographic separation conditions, TET proteins have been
shown to be capable of further oxidizing 5hmC to 5fC and
5caC (He et al., 2011; Ito et al., 2011) (Figure 1B). Mass
spectrometry analysis has shown that 5fC is present in a
wide-range of cell types and 5caC is detectable in mouse
ESCs, although their levels are at least an order of magnitude
less than that of 5hmC (He et al., 2011; Ito et al., 2011; Pfaffe-
neder et al., 2011). The low abundance of 5fC and 5caC is
partially due to the presence of specific enzymatic activity
capable of efficiently excising these highly oxidized bases
from DNA (see below). Thus, TET-mediated 5mC oxidation
reactions extend the previously recognized binary state of cyto-
sine modification (C/5mC) to five distinct states (C/5mC/5hmC/5fC/5caC) in the mammalian genome, raising the possibility
that these new cytosine analogs may play a role in dynamic
regulation of 5mC.
Passive Restoration of Unmodified Cytosines by
Replication-Dependent Dilution of Oxidized 5mC
The presence of oxidized 5mC bases at CpG sites may facilitate
replication-dependent passive loss of 5mC. While there are
conflicting results regarding whether UHRF1 can efficiently
recognize hemihydroxymethylated CpG sites (hCG:GC) (Frauer
et al., 2011; Hashimoto et al., 2012), independent studies have
established that DNMT1 is significantly less efficient (1060-
fold) in methylating hCG:GC than hemimethylated (mCG:GC)
sites in vitro (Hashimoto et al., 2012; Valinluck et al., 2004).
Whether hemimodified CpGs carrying 5fC or 5caC (XG:GC,
X = fC or caC) also impair DNMT1 functions is unclear. In sum-
mary, TET proteins may initiate a two-step demethylation
process in proliferating cells that involves initial active modifica-
tion (AM) of 5mC through oxidation and subsequent replication-
dependent passive dilution (PD) of 5hmC and potentially 5fC/
5caC (AM-PD in Figure 2A). This mode of active DNA demethy-
lation is distinct from simple passive dilution of 5mC (PD in
Figure 2A) (Kohli and Zhang, 2013), as AM-PD may be effective
even in the presence of functional methylation maintenance
machinery. Replication-dependent DNA demethylation in the
presence of DNMT1/UHRF1 has been reported during erythro-
poiesis (Shearstone et al., 2011), it will be interesting to examine
whether 5mC oxidation may contribute to DNA demethylation in
this system.
Interestingly, DNMT3A/B has comparable in vitro methylase
activity toward mCG:GC and hCG:GC sites (Hashimoto et al.,
2012; Otani et al., 2013b), suggesting that DNMT3 may be
involved in maintaining 5mC levels in dividing cells with
high TET activity. In support of this notion, mouse ESCs
deficient in both DNMT3A and DNMT3B become globally hypo-
methylated after prolonged culturing (Chen et al., 2003).
Because 5hmC/5fC/5caC in the paternal genome can be
passively diluted in the presence of maternal DNMT3A pro-
teins during early preimplantation development (Inoue et al.,
2011; Inoue and Zhang, 2011), DNMT3A alone may not be
sufficient to effectively methylate hemimodified sites (XG:GC,
X = hC, fC, or caC). Further studies are needed to elucidate
the interplay between 5mC oxidation and replication-depen-
dent demethylation.
Active Restoration of Unmodified Cytosines by
Enzymatic Removal of Oxidized 5mC
In addition to passive dilution of modified cytosines, several TET
initiated but replication-independent active demethylation
mechanisms have been proposed (Box 1B). These active DNA
demethylation processes also involve initial oxidative modifica-
tion of 5mC but complete the demethylation through replica-
tion-independent active restoration (AR) of unmodified C. First,
removal of oxidized 5-position substituent, through either de-
hydroxymethylation of 5hmC by DNMTs (Chen et al., 2012; Liut-
keviciute et al., 2009) or decarboxylation of 5caC by a putative
decarboxylase (Schiesser et al., 2012; Wu and Zhang, 2010),
may directly revert the oxidized 5mC base to unmodified cyto-
sine. Second, DNA glycosylase-mediated excision of oxidized
5mC bases, including removal of 5hmU (deamination productCell 156, January 16, 2014 ª2014 Elsevier Inc. 49
of 5hmC) (Guo et al., 2011) or 5fC/5caC (He et al., 2011;Maiti and
Drohat, 2011), may result in abasic sites that are further repaired
by BER to restore unmethylated C.
Among these proposed TET-dependent AM-AR demethyla-
tion pathways, themechanism that involves TDG-mediated exci-
sion of 5fC/5caC has received the most experimental support.
As a member of uracil DNA glycosylase (UDG) superfamily
(Figure 1A), TDG is known to use a base-flipping mechanism to
remove the pyrimidine base from T,G or U,G mismatches to
initiate BER (Stivers and Jiang, 2003). Given the precedent
of DME/ROS1-mediated excision repair of 5mC in plants
(Figure 1C), DNA glycosylases have long been suspected in
playing a role in active DNA demethylation in mammals. TDG is
a particularly attractive candidate as it can act as a scaffold
protein to bridge transcriptional coactivator CBP/p300 to
numerous transcription factors, supporting a gene regulatory
role of TDG (Dalton and Bellacosa, 2012). Early studies sug-
gested that TDG might promote DNA demethylation through
either direct excision of 5mC or T (the deamination product of
5mC). Although biochemically feasible, thesemechanisms prob-
ably play a limited role in DNA demethylation given the marginal
5mC excision activity of TDG and AID/APOBEC deaminases’
selectivity for single-stranded DNA (Box 1A). The role of TDG in
DNA demethylation was revisited after additional oxidized cyto-
sine analogs were discovered in the genome. While TDG cannot
efficiently remove 5mC or 5hmC, it exhibits robust in vitro exci-
sion activity toward 5fC or 5caC (5fC,G or 5caC,G pairs) in
duplex DNA (He et al., 2011; Maiti and Drohat, 2011). In fact,
TDG has a higher activity for 5fC,G compared to T,Gmismatch,
its cognate substrate (Maiti and Drohat, 2011). The molecular
basis for excision of 5fC/5caC by TDG stems from the effect of
5fC and 5caC in destabilizing the base-sugar linkage (N-glyco-
sidic bond) as C bases with a weakened N-glycosidic bond
can be efficiently excised by DNA glycosylases (Bennett et al.,
2006). Further biophysical analysis indicates that the active
site of TDG may possess specific structural features to mediate
the recognition of oxidized 5mC bases (Zhang et al., 2012).
Supporting the physiological relevance of this mechanism, over-
expression of TET and TDG in the HEK293 cells rapidly depleted
5fC and 5caC (Nabel et al., 2012), whereas Tdg-deficiency in
mouse ESCs caused a 5- to 10-fold increase in levels of 5fC
and 5caC (He et al., 2011; Shen et al., 2013; Song et al.,
2013a). Thus, methylation, iterative oxidation and excision
repair offer a complete cytosine-modifying cascade that permits
replication-independent erasure of DNA methylation (Figures 1C
and 2B).
While other members of the UDG family of DNA glycosylases
(UNG, MBD4, and SMUG1) are dispensable for embryonic
development (Kemmerich et al., 2012; Millar et al., 2002), Tdg
null mouse embryos exhibit a wide range of developmental
defects and die around embryonic day (E) 12.5 (Corta´zar et al.,
2011; Cortellino et al., 2011). Interestingly, among all UDG DNA
glycosylases, only TDG can efficiently excise 5fC/5caC (He
et al., 2011; Maiti and Drohat, 2011), suggesting a unique role
of TDG’s 5fC/5caC excision activity in embryonic development.
Indeed, mutant embryos carrying the glycosylase activity defec-
tive mutation (N151A in mouse TDG) phenocopy developmental
defects of Tdg null embryos (Cortellino et al., 2011). Given its50 Cell 156, January 16, 2014 ª2014 Elsevier Inc.robust excision repair activity for mismatch mutations, TDG
may potentially ensure proper development by reducing genetic
mutations; however, Tdg-deficiency induced embryonic lethality
phenotype was fully penetrant, which is incompatible with an
antimutagenic DNA repair defect that would exhibit highly vari-
able phenotypes due to stochastic mutations in different genes.
Thus, inactivation of TDG may primarily result in epigenetic
rather than genetic defects in the genome. Dys-regulation of
C/5mC/5hmC levels and/or accumulation of ectopic 5fC/5caC
at specific gene regulatory sequences in Tdg-deficient mice
may potentially affect transcription and cause developmental
defects. Further in vivo analysis is needed to clarify how exten-
sive TET/TDG-mediated DNA demethylation pathway is utilized
in vivo and to elucidate the exact mechanism by which TDG
activity contributes to transcription and development.
Intermediate Steps of TET/TDG-Mediated Replication-
Independent DNA Demethylation
Considering the cytosine methylation and demethylation pro-
cess in the context of TET/TDG-mediated step-wise enzymatic
cascade prompts key mechanistic questions: does TET enzyme
act on DNA substrates processively or distributively for the three
successive oxidation reactions? What are the preferred inter-
mediate steps through which TET and TDG enzymatically revert
5mC to unmodified cytosine? Does TDG-mediated excision of
5fC/5caC preferentially generate single-strand break (SSB) or
double-strand break (DSB)? Base-resolution mapping studies
showed that steady-state 5hmC is almost exclusively found in
the CpG context (>99% in CpGs), even in mouse ESCs and
neurons where non-CpG methylation is prevalent (Lister et al.,
2013; Yu et al., 2012). Thus, oxidative modification of 5mC by
TET proteins may occur mostly in the CpG context. In line with
this, recent structural and biochemical analyses of human
TET2 catalytic domain or Naegleria Tet-like dioxygenase
(NgTet1) indicate that these 5mC oxidases have a stronger pref-
erence to oxidize 5mC in CpG sites than in non-CpG context
(Hashimoto et al., 2013; Hu et al., 2013). Alternatively, iterative
oxidation of 5mC at non-CpG sites could occur at a much faster
rate such that 5hmC at these sites is only transiently generated
and rapidly converted to 5fC/5caC, which are removed by
TDG/BER. Base-resolution mapping of 5fC/5caC in Tdg mutant
cells can potentially capture these short-lived oxidized 5mC
bases within non-CpG sites.
Within each CpG dyad, the cytosine-modifying pathway
(DNMT-TET-TDG/BER) can theoretically generate 21 distinct
cytosine modification states (XG:GX, X = C, mC, hmC, fC, caC or
abasic), six of which are in symmetric form (Figure 2B). Base-
resolution mapping of 5hmC in mouse ESCs indicates that less
than 20% of 5hmC is potentially present in symmetrically modi-
fied form (hmCG:GChm) (Yu et al., 2012). Furthermore, crystal
structures of TET2 or NgTet1 in complex with DNA containing
mCG:GCm suggest that TET enzymes initiate the oxidation
reaction by DNA bending and base flipping, and act on a single
5mC from a symmetrically methylated CpG site (Hashimoto
et al., 2013; Hu et al., 2013). Thus, hemimodified CpG dyads
may be the predominant pool of intermediates generated from
5mC oxidation reactions. Strand asymmetry associated with
5hmC (or 5fC and 5caC) implies that TET/TDG-mediated active
demethylation may frequently generate single abasic site at
methylated CpGs, which typically leads to formation of SSB.
Reducing the frequency of symmetrically oxidized CpGs
(XG:GX, X = fC or caC) may be physiologically relevant as two
abasic sites in a single CpG dyad (XG:GX, X = abasic) could
frequently generate DSB, increasing the chance of introducing
deleterious mutations. Curiously, in vitro biochemical assay
showed that TDG has higher excision activity for hemicarboxyl-
methylated CpG site (caCG:GC) than for fully carboxylmethylated
one (caCG:GCca) (He et al., 2011), which may also help reduce
frequency of generating DSB. Sequencing technology that
allows simultaneous mapping of 5fC and 5caC at base-resolu-
tion may help determine the relative frequency of SSBs versus
DSBs introduced during TET/TDG-mediated active demethyla-
tion process.
Regulatory Mechanisms of TET-Dependent DNA
Demethylation
Maintaining proper gene expression and cellular identity requires
precise control of the DNA methylation pattern (Ji et al., 2010;
Ziller et al., 2013). 5mC is likely to be the default epigenetic state
of CpGs (except for those within CpG-rich promoters) in the
mammalian genome, thus direct regulation of DNA methylation
machineries generally leads to global changes in 5mC levels;
however, regulatory mechanisms that modulate substrate
accessibility, enzymatic activity, expression levels, and genomic
targeting of TET enzymes may provide more precise control of
the pattern of 5mC (or oxidized 5mC) at specific loci in the
genome.
Regulation by Substrate Preference and Accessibility of
TET Enzymes
Quantitative mass spectrometry analysis of mouse ESCs
suggests that 5hmC (5% of 5mC) is significantly more
prevalent than 5fC (0.06%–0.6% of 5mC) and 5caC (0.01%
of 5mC) (Ito et al., 2011; Pfaffeneder et al., 2011), suggesting
that TET enzymes tend to stall at 5hmC. The processivity of
5mC oxidation may be regulated by substrate preference
and/or the accessibility of TET enzymes. In vitro biochemical
analysis suggests that the initial reaction rate of TET
enzymes for oxidizing 5mC to 5hmC is significantly higher
than that of oxidizing 5hmC or 5fC (Hashimoto et al., 2013;
Ito et al., 2011), indicating that TET proteins may be more
efficient in utilizing 5mC (as compared to 5hmC or 5fC) as a
substrate. Structural analysis of TET2 catalytic domain shows
that the methyl group of 5mC is not involved in the TET2-
DNA interaction, thus allowing the active site to accommodate
oxidized 5mC derivatives for further oxidation (Hu et al., 2013).
It remains to be determined whether the active site of TET
enzymes has distinct affinity for 5mC, 5hmC, and 5fC. Interest-
ingly, a SRA domain-containing protein, UHRF2, has been
recently identified as a 5hmC-binding protein and reported to
be able to enhance the processivity of TET enzymes (Spruijt
et al., 2013), potentially via its ability to flip modified cytosine
from DNA duplex and increase the substrate accessibility of
TET proteins.
Regulation of Enzymatic Activity by Metabolites and
Cofactors
Emerging evidence indicates that changes of metabolic states
in cells may affect the relative concentration of enzymatic cofac-tors and in turn influence the activity of DNA and histone-modi-
fying enzymes (Kaelin and McKnight, 2013). TET enzymes
require oxygen, Fe (II) and a-KG to catalyze 5mC oxidation reac-
tions. a-KG is primarily produced from isocitrate in the tricarbox-
ylic acid (TCA) cycle by isocitrate dehydrogenases 2 and 3 (IDH2
and IDH3) in the mitochondria. Cytosolic IDH1 can provide an
alternative source of a-KG. Interestingly, inactivating mutations
in the TCA cycle enzymes, fumarate hydratase (FH) and succi-
nate dehydrogenase (SDH), or tumor-associated missense
mutations in IDH1/2 result in accumulation of high concentra-
tions of fumarate, succinate, and the oncometabolite 2-hydroxy-
glutarate (2-HG), all of which share structural similarity with a-KG
and competitively inhibit Fe(II)/a-KG-dependent dioxygenases
(Kaelin and McKnight, 2013), including TET enzymes and
JmjC-domain-containing histone demethylases (Klose et al.,
2006).
Vitamin C (also known as ascorbic acid), a micronutrient
known for its antiscurvy activity in humans, is also implicated
in modulation of TET activity. Recent studies have supported a
role of vitamin C in stimulating the catalytic activity of TET
proteins (Blaschke et al., 2013; Minor et al., 2013; Yin et al.,
2013). Vitamin C may directly interact with the catalytic domain
of TET proteins and act as a positive modulator of TET activity
by facilitating conformational changes and/or recycling of the
cofactor Fe (II) (Yin et al., 2013). In mouse ESCs, vitamin C signif-
icantly increases levels of all 5mC oxidation products, particu-
larly 5fC and 5caC (>10-fold). Moreover, ground-state mouse
ESCs cultured in the presence of vitamin C adopt a methylome
more resembling that of blastocysts in vivo (Blaschke et al.,
2013).
Regulation of Genomic Targeting of TET Enzymes
In addition to the C-terminal catalytic domain, TET1 and TET3
encode a zinc finger Cystein-X-X-Cystein (CXXC) domain at
their N-termini (Figure 1A). The CXXC domain is present in
many chromatin-associated proteins and has a strong prefer-
ence for unmethylated CpGs (Long et al., 2013). Although
TET2 lacks a CXXC domain, a neighboring gene IDAX (inhibi-
tion of the Dvl and axin complex; also known as CXXC4)
encodes a CXXC domain highly similar to those in TET1 (also
known as CXXC6) and TET3 (CXXC10). It is possible that
IDAX was originally part of an ancestral TET2 gene that under-
went a chromosomal inversion, which separated the CXXC
domain from the catalytic domain (Iyer et al., 2009; Ko et al.,
2013). Genome-wide occupancy analysis suggests that TET1
is preferentially localized to unmethylated CpG-rich promoters
and genic regions in mouse ESCs (Williams et al., 2011; Wu
et al., 2011b), and IDAX is also enriched at unmethylated
CpG sequences and directly interacts with TET2 (Ko et al.,
2013). Further biochemical and structural analyses indicate
that TET1 CXXC domain may also recognize methylated cyto-
sines (Xu et al., 2011b; Zhang et al., 2010), and the TET3
CXXC domain can target unmethylated cytosines within both
CpG and non-CpG contexts (Xu et al., 2012). Thus, unlike
other CXXC domains that specifically recognize unmethylated
CpG sites, CXXC domains of TET1/3 and IDAX may have
increased flexibility in sequence selectivity and play a role in
facilitating the recruitment of TET enzymes to their specific
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Transcriptional and Posttranscriptional Regulation of
TET Levels
Three TET genes exhibit different expression patterns in a
developmental-stage- and cell-type-specific manner (Ito
et al., 2010; Szwagierczak et al., 2010). A high-level of TET1
is specifically detected in mouse ESCs, the inner cell mass
of blastocysts, and developing PGCs (E9.5-12.5), whereas
TET2 and TET3 are broadly expressed in various mouse
adult tissues (Ito et al., 2010; Yamaguchi et al., 2012). Interest-
ingly, TET3 is the only TET enzyme present in mouse oocytes
and one-cell zygotes (Iqbal et al., 2011; Wossidlo et al.,
2011). Transcriptional control of TET genes is likely mediated
by cell-type-specific transcription factors. For instance, the
upstream promoter region of the TET1 gene contains a large
cluster of binding sites for pluripotency-related transcription
factors (TFs) (Ficz et al., 2011), suggesting a role of pluripo-
tency-related TFs in maintaining TET1 expression. Indeed,
TET1 is highly expressed in mouse ESCs, but its level is rapidly
downregulated upon differentiation (Ito et al., 2010; Koh et al.,
2011).
Given the relatively large size of mRNA and 30 untranslated
regions (UTR) of TET1-3 genes, TET mRNAs may also be regu-
lated posttranscriptionally by microRNAs. Indeed, two recent
studies have reported a role of oncogenic microRNA miR-22 in
negatively regulating TET protein levels in the context of breast
cancer development and hematopoietic stem cell transforma-
tion (Song et al., 2013b; Song et al., 2013c). In addition, IDAX
may target TET2 proteins for degradation via a caspase-
dependent mechanism; similarly, the CXXC domain of TET3
may negatively regulate its own protein stability (Ko et al.,
2013), suggesting an auto-inhibitory mechanism of regulating
TET protein levels.
Genomic Distribution of Oxidized Methylcytosines and
Their Potential Roles in Transcription Regulation
Genome-wide mapping of oxidized 5mC bases in the mamma-
lian genome represents an unbiased approach to investigate
the potential roles of TET-mediated demethylation pathway
and these oxidized cytosines in epigenome function and tran-
scriptional regulation. In principle, DNMT and TET enzymes
can modify each of the approximately 28 million CpGs in the
diploid mammalian genome to adopt one of the five epigenetic
states (C/5mC/5hmC/5fC/5caC).
Genome-wide Mapping Technologies for Oxidized 5mC
Bases
Multiple methods exploiting specific biochemical or biophysical
properties of modified cytosine bases have been developed to
map their distribution across the genome (Figure 3A). These
methods can be categorized into two groups: first, affinity-
enrichment-based approaches, which utilize modification-
specific antibodies or selective chemical labeling of modified
cytosines (Box 2A); second, base-resolution mapping methods
such as bisulfite sequencing (BS-Seq) (Box 2B). The affinity-
based methods are generally straightforward to perform and
more cost-effective. However, the resolution of these methods
is limited by the size of DNA fragments (several hundred base
pairs), and affinity-enrichment methodology identifies regions
enriched for modified bases by comparing signals (normalized52 Cell 156, January 16, 2014 ª2014 Elsevier Inc.sequencing read counts) in pull-down and those in negative con-
trol (IgG or input), thereby providing a measurement of relative
fold-enrichment (pull-down/control). By contrast, base-resolu-
tion mapping of modified bases can determine which cytosine
(including exact position and strand) is modified and typically
measures the percentage of modification level ((number of modi-
fied cytosines/number of all cytosines)3 100%) at a given cyto-
sine. The probability that a cytosine can be confidently identified
as modified is governed by the sequencing depth and abun-
dance of the modification at that cytosine in a specific cell
type. Given the low abundance of oxidized methylcytosines,
base-resolution methods require a relatively high sequencing
depth to detect them. It has been estimated that at a normal
sequencing depth (20–303 for BS-Seq), base-resolution map-
ping of 5hmC (TAB-seq in Figure 3A and Box 2B) can confidently
detect cytosines with an average 20% or higher level of hydrox-
ymethylation regardless of the local density of cytosine sub-
strates (Yu et al., 2012). As a result, base-resolution methods
have enhanced sensitivity for detecting individual cytosine that
is modified at medium-to-high level but sparsely distributed
(that is, not clustered with other 5hmC). Indeed, while 80%–
90% of 5hmC peaks identified by affinity-based methods (e.g.,
5hmC antibody IP and GLIB in Figure 3A) contain at least one
of the approximately 2.06million high-confidence 5hmC-marked
cytosines detected by TAB-seq in mouse ESCs, 5hmC peaks
from affinity-based methods only cover 30%–40% of high-con-
fidence 5hmC identified by TAB-seq (Yu et al., 2012). Because
affinity-based methods integrate signals from multiple cytosines
within a given genomic region, they are capable of detecting
closely clustered cytosines with low level of modification, which
may otherwise be missed by base-resolution methods. Further
increasing the sequencing depth of base-resolution mapping
experiments may help identify cytosines carrying low-level
modification, although it is unclear whether these infrequently
modified cytosines are biologically relevant. In summary,
both affinity-based and single-base mapping methods can
consistently identify regions enriched for cytosines that are
frequently modified (medium-to-high level), but their results
may differ at sparsely distributed or infrequently modified cyto-
sines. Discrepancies between published genome-wide mapping
studies may be due to the use of different methodologies and
data analysis strategies as well as varying definition of a given
genomic feature. Here, we focus on recent advances on map-
ping of oxidized 5mC bases including 5fC/5caC in stem cells
and their potential gene regulatory roles at various genomic
features.
Oxidized Methylcytosines at Gene Promoters
Approximately 70% of mammalian promoters are associated
with short CpG-dense sequences (termed CpG islands [CGIs],
on average 1 kilobase [kb] long) (Deaton and Bird, 2011). CpG-
rich promoters (also known as high-CpG promoters [HCPs])
are generally unmethylated and transcriptionally active as
H3K4 methylation and histone variant H2A.Z enriched at these
HCPs antagonize DNMT binding (Ooi et al., 2007; Zilberman
et al., 2008). The lack of 5mC at HCPs predicts that TET-
mediated oxidative modification of 5mC is minimal at these pro-
moters. Indeed, the current consensus view from both affinity-
enrichment and base-resolution mapping studies suggests that
Figure 3. Genome-wide Mapping Methods
for Cytosine Modifications
(A) Summary of BS-seq or affinity-enrichment
based genome-wide mapping methods of DNA
cytosinemodifications. In conjunction with various
chemical and enzymatic pretreatment, BS-seq or
affinity-enrichment (antibody or chemical tagging)
methods have been developed to map 5mC (BS-
seq and oxBS-seq; 5mC DNA immunoprecipita-
tion (DIP)), 5hmC (oxBS-seq and TAB-seq; 5hmC
DIP, CMS IP, JBP1 IP, GLIB, and hMe-Seal), 5fC
(fCAB-seq; 5fC DIP, fC-Seal, and 5fC pull-down),
and 5caC (caCAB-seq; 5caC DIP) (see Box 2).
Notably, oxBS-seq, fCAB-Seq, and caCAB-seq
require subtracting signals of conventional BS-
seq from those of modified BS-seq to indirectly
determine the position and abundance of oxidized
5mC bases. 5fC and 5caC have not been sys-
tematically mapped at base-resolution, as they are
relatively rare in the wild-type cells and require
unusually high sequencing coverage to confi-
dently determine their position and abundance.
(B) Shown are genomic distributions of oxidized
5mC bases at representative loci in mouse ESCs.
Genomic distribution of 5hmC/5fC/5caC in control
(WT: wild-type; Ctrl kd: control knockdown) and
Tdg-depleted (ko: knockout; Tdg kd: Tdg knock-
down) mouse ESCs are shown for three repre-
sentative loci. 5hmCdistribution wasmeasured by
both affinity-based method (5hmC DIP, CMS,
hMe-Seal, and GLIB) (Pastor et al., 2011; Shen
et al., 2013; Song et al., 2013a) and base-resolu-
tion method (TAB-Seq, scale: 0%–50%) (Yu et al.,
2012). Distributions of 5fC and 5caC were deter-
mined by antibody (5fC/5caC DIP) (Shen et al.,
2013) or chemical tagging (fC-Seal) (Song et al.,
2013a) methods. DNA methylation levels were
estimated by 5mC DIP (Shen et al., 2013) or con-
ventional BS-seq (5mC+5hmC, scale: 0%–100%)
in wild-type mouse ESCs (Stadler et al., 2011).
Based on local methylation levels, the genome can
be categorized into FMRs (fully methylated
regions, 50%–100% methylation), LMRs (low
methylated regions, 10%–50%), and UMRs (un-
methylated regions, < 10%) (Stadler et al., 2011).
Also shown are other genomic data sets in wild-
type mouse ESCs, including TET1 ChIP-seq (Wu
et al., 2011b), RNA-seq (Ficz et al., 2011), major
histone modifications (Mikkelsen et al., 2007),
DNase I hypersensitivity site (modENCODE proj-
ect), and binding sites of pluripotency TFs (Whyte
et al., 2012). A region located upstream of Zfp281
gene is highlighted in gray, where Tdg-deficiency
induced ectopic 5caC is overlapped with chro-
matin features of active enhancer (DNase I+/
H3K4me1+/H3K4me3) and binding sites of plu-
ripotency factors (Oct4/Nanog/Sox2).proximal regions surrounding the transcriptional start site (TSS)
of active promoters (mostly HCPs) are generally devoid of
5hmC/5fC/5caC in both wild-type and Tdg-depleted mouse
ESCs (exemplified by promoters of Rest and Zfp281 in
Figure 3B, overlapping with unmethylated regions [UMR])
(Shen et al., 2013; Song et al., 2013a; Szulwach et al., 2011a;
Wu et al., 2011a; Yu et al., 2012). TET proteins enriched atCell 15CpG-rich active promoters may there-
fore facilitate steady-state transcription
through catalytic activity-independentfunctions such as stabilizing or recruiting other chromatin-modi-
fying complexes (Box 3).
Affinity-based methods showed that 5hmC is preferentially
enriched at promoters of genes expressed at medium-to-low
levels in mouse and human ESCs (Pastor et al., 2011; Szulwach
et al., 2011a;Wu et al., 2011a; Xu et al., 2011b), and these 5hmC-
enriched promoters are generally associated with intermediate6, January 16, 2014 ª2014 Elsevier Inc. 53
Box 2. Genome-wide Mapping Technologies for 5mC Oxidation
Products
A. Affinity-Enrichment Methods
Affinity-enrichment is achieved by using either modification-specific
antibodies or chemical-tagging-specific 5mC oxidation derivatives
(Figure 3A).
1. Antibody-Based Immunoprecipitation (IP) of 5hmC/5fC/5caC
Modification-specific antibodies are available for all three
oxidized 5mC bases and the IP procedure is simple (Song et al.,
2012b; Wu and Zhang, 2011a). However, there is evidence that
antibody-based method may pull-down certain type of simple
repeats (e.g., poly-CA) nonspecifically (Matarese et al., 2011).
Subtracting IgG control signals from IP signals can partially alle-
viate this problem (Shen et al., 2013).
2. CMS Antibody-Based IP of 5hmC
This method is based on sodium bisulfite-mediated conversion of
5hmC to cytosine methylene sulphonate (CMS). Highly specific
antibody against CMS can be generated and used to enrich
5hmC-containing DNA fragment (Huang et al., 2012). Anti-CMS
serum may have lower background compared to anti-5hmC
serum (Pastor et al., 2011). However, the presence of bulky CMS
moiety in DNA can introduce PCR biases.
3. JBP1 IP of 5hmC
The method involves initial conversion of 5hmC to glycosylated
5hmC (g5hmC) using b-glucosyltransferase (b-GT) from T4
bacteriophage. JBP1, a natural g5hmC-binding protein, is then
used to enrich g5hmC-containing genomic DNA (Robertson et al.,
2011). However, a recent study suggests that JBP1 IP generally
produces weaker signals compared to 5hmC antibody IP or hMe-
Seal (Thomson et al., 2013).
4. Selective Chemical Labeling 5hmCwith Biotin (hMe-Seal or GLIB)
By exploiting the naturally occurring glucosylation process of
5hmC by b-GT, several methods were developed to chemically
and enzymatically label 5hmC with the biotin tag (Pastor et al.,
2011; Song et al., 2011; Szwagierczak et al., 2010). The highly
selective and strong interaction between biotin and streptavidin
allows efficient pull-down of 5hmC-containing DNA. In the first
method, termed hMe-Seal (Song et al., 2011), purified b-GT is
used to transfer an azide-modified glucose analog (UDP-6-N3-
glucose) to 5hmC. Then, a biotin group can be attached to g5hmC
with alkyne-biotin probe via click chemistry (Song et al., 2011).
The second approach, named GLIB (glucosylation, periodate
oxidation, biotinylation), first uses b-GT to transfer an unmodified
glucose to 5hmC. Next, sodium periodate (NaIO4) is used to
oxidize the vicinal hydroxyl group in the glucose to aldehyde
group, which is further modified with aldehyde-reactive probe
(aminooxy-biotin or NH2O-biotin) to add biotin tag to g5hmC
(Pastor et al., 2011). These chemical labeling methods have
enhanced sensitivity and lower background as compared to the
antibody-based method (Song et al., 2012b). However, similar to
5hmC antibody IP, these methods still exhibit some degree of
density-dependency and tend to more efficiently pull-down DNA
fragment containing multiple modified bases (Shen et al., 2013).
5. Selective Chemical Labeling 5fC with Biotin (fC-Seal or 5fC Pull-
Down)
A strategy for direct labeling 5fC with biotin tag using aminooxy-
biotin probes has been suggested (Pfaffeneder et al., 2011) and
was used to generate the genome-wide distribution map of 5fC
(Raiber et al., 2012). However, this method may have side reac-
tions with other cytosines or abasic sites, resulting in relatively
high background. Based on hMe-Seal, an indirect 5fC labeling
method (termed fC-Seal) has been developed (Song et al., 2013a).
In fC-Seal, b-GT is first used to block endogenous 5hmC in the
genome with unmodified glucose. Next, sodium borohydride
(NaBH4) is used to reduce 5fC to 5hmC, which is further converted
to g5hmC-biotin (derived from endogenous 5fC) as in hMe-Seal.
B. Single-Nucleotide Resolution Methods
Base-resolution mapping of 5mC oxidation derivatives involves the
use of bisulfite sequencing (BS-seq) or third-generation sequencing
platforms.
1. BS-Seq (5mC+5hmC)
In standard BS-seq, 5mC and 5hmC are resistant to deamination
and consequently be read out as C after PCR amplification (Clark
et al., 1994). In contrast, unmodified C, 5fC and 5caC are deam-
inated in bisulfite treatment and read out as T in sequencing. Thus,
methylation signals (C) in standard BS-seq represent the sum of
5mC and 5hmC, complicating the interpretation of BS-seq results
(Huang et al., 2010). By exploiting distinct chemical properties of
5hmC/5fC/5caC in bisulfite treatment (NaHSO3), traditional BS-
seq can be adapted to map oxidized 5mC (Figure 3A).
2. oxBS-Seq (5hmC)
In oxidative bisulfite sequencing (oxBS-seq) (Booth et al., 2012),
potassium perruthenate (KRuO4) was used to specifically oxidize
5hmC to 5fC, which can be deaminated by bisulfite treatment.
After the DNA sample is treated with KRuO4 and NaHSO3, 5hmC/
5fC/5caC is detected as T in sequencing, whereas 5mC remains
intact and is read as C. Therefore, subtracting signals of oxBS-seq
maps from standard BS-seq signals would reveal the location and
abundance of 5hmC (Booth et al., 2012).
3. TAB-Seq (5hmC)
In TET-assisted bisulfite sequencing (TAB-seq) (Yu et al., 2012),
5hmC is first protected from TET-mediated oxidation by gluco-
sylation using b-GT. Next, 5mC and 5fC are oxidized to 5caC in
the presence of highly active recombinant TET proteins.
4. fCAB-Seq (5fC)
In this chemical modification assisted BS-seq (CAB) method,
O-ethylhydroxylamine (EtONH2) is used to prevent 5fC from
bisulfite-mediated deamination (Song et al., 2013a). Subtracting
standard BS-seq signals from signals of fCAB-seq will reveal the
location and abundance of 5fC.
5. caCAB-Seq (5caC)
Similar to fCAB-seq, 5caC can be modified by 1-ethyl-3-[3-
dimethylaminopropyl]-carbodiimide hydrochloride (EDC) to resist
deamination (Lu et al., 2013). However, this methodmay have side
reactions with the genomic DNA.
6. Third-Generation Sequencing Technology
These single-molecule sequencing technologies directly
sequence DNA molecules without the need of PCR amplification.
In single-molecule real-time (SMRT) sequencing, real-time
recording of nucleotide incorporations generates not only the
sequence identity but also DNA polymerase kinetics. The poly-
merase replication rate at and aroundmodified cytosines is slower
compared to unmodified bases. When combined with chemical
labeling or enzymatic modification (adding a glucosyl group to
5hmC; oxidizing 5mC to 5caC) to increase kinetic differences,
SMRT can be used to detect strand-specific 5mC and oxidized
bases at base-resolution with high confidence (Clark et al., 2013;
Song et al., 2012a). Nanopore sequencing monitors the current
signal when individual DNA molecular pass through nanoscale
protein pores and has also shown the potential to detect oxidized
5mC bases (Li et al., 2013; Wanunu et al., 2011). While third
Box 2. Continued
(Continued on next page)
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generation sequencing technologies have the potential to directly
map various cytosine modifications, significant technological
advances are required to further improve the detection accuracy
and to increase the sequencing throughput for analyzing complex
mammalian genomes.
Box 2. Continued Box 3. Catalytic Activity-Independent Role of TET Proteins in
Transcriptional Regulation
Genomic mapping of TET proteins in ESCs, HEK293T cells and bone
marrow tissues suggest that all three TET proteins are preferentially
localized to unmethylated CpG-rich promoters (Chen et al., 2013b; De-
plus et al., 2013; Vella et al., 2013; Williams et al., 2011; Wu et al.,
2011b). In mouse ESCs, TET1 is highly enriched at actively transcribed
CpG-rich promoters as well as bivalent gene promoters, which are
repressed by Polycomb repression complex 2 (PRC2). The preference
for CGIs is likely due to its N-terminal CXXC domains. Depletion of
TET1 causes transcriptional activation and repression of many direct
TET1 targets (Williams et al., 2011; Wu et al., 2011b; Xu et al.,
2011b). These results suggest that TET proteins may have dual func-
tions in transcriptional regulation via distinct mechanisms. The tran-
scriptional activation role of TET1may be dependent on its 5mC oxida-
tion activity to maintain unmethylated states at active promoters or
distal enhancers (Ficz et al., 2011; Shen et al., 2013; Wu et al.,
2011b); in contrast, a role of TET1 in transcriptional repression may
be related to its physical interaction with the SIN3A repressor complex
(Williams et al., 2011), or its ability to facilitate the recruitment of the
MBD3/NURD (Yildirim et al., 2011) and PRC2 (Wu et al., 2011b) to
chromatin. TET2 and TET3 (to a lesser extent for TET1), can directly
interact with O-linked b-N-acetylglucosamine (O-GlcNAc) transferase
(OGT), and recruit OGT to CpG-rich gene promoters in mouse ESCs
and differentiated cells (Chen et al., 2013b; Deplus et al., 2013; Vella
et al., 2013). Although this physical interaction appears not to regulate
enzymatic activity of TET proteins, depletion of TET proteins reduces
OGT binding to chromatin and its activity to glycosylates histone
H2B (Chen et al., 2013b) and other chromatin regulators such as
HCF1 (host cell factor 1) (Deplus et al., 2013), a component of the
H3K4 methyltransferase SET1/COMPASS complexes. Thus, TET pro-
teins may promote transcription of target genes by enhancing histone
modifications such as O-GlcNAcylation at Ser 112 of H2B and trime-
thylation of Lys 4 on H3 (H3K4me3), both of which are associated
with gene activation. Together, these results suggest that TET proteins
possess catalytic activity-independent gene regulatory functions.or low CpG-density (intermediate-CpG promoter [ICP] or low-
CpG promoter [LCP]). Base-resolution mapping of 5hmC also
indicated that 5hmC is more abundant at ICPs/LCPs than at
HCPs (Yu et al., 2012). Recent studies showed that 5fC/5caC
tend to accumulate at transcriptionally inactive or poised pro-
moters in the absence of TDG in mouse ESCs (Shen et al.,
2013; Song et al., 2013a). In fact, some of the highest levels of
5hmC/5fC/5caC in Tdg-depleted mouse ESCs are found at pro-
moters and flanking regions of lineage-specific transcription fac-
tor (mostly ICPs) (Tbx5 in Figure 3B) (Shen et al., 2013), indicating
that TET/TDG-mediated active demethylation occurs at these
loci. 5hmC/5fC/5caC peaks at or surrounding these ICPs of line-
age-specific genes are frequently overlapped with low-methyl-
ation regions (LMRs) that are previously identified by standard
BS-seq as partially methylated regions (Stadler et al., 2011), as
well as bivalent domains,which containH3K4me3 (active histone
mark) and H3K27me3 (polycomb repression complex 2 [PRC2]-
deposited repressive mark) (Bernstein et al., 2006). TET proteins
and oxidized methylcytosines may contribute to the establish-
ment and/or maintenance of transcriptionally poised/inactive
state at lineage-specific promoters through several mecha-
nisms, including maintenance of partially methylation state by
mediating active demethylation, recruitment of TET-interacting
corepressor complexes such as SIN3A (Box 3), and attracting/
repelling specific reader proteins for oxidized 5mC bases (see
below). Further studies are needed to clarify the relative impor-
tance of these distinct mechanisms in gene regulation.
Oxidized Methylcytosines within Gene Bodies
Enrichment of 5hmC within intragenic regions, particularly at 30
portion of gene bodies, is found to be a hallmark of active
transcription in virtually all cell-types investigated, including
mouse/human ESCs (Ficz et al., 2011; Pastor et al., 2011; Szul-
wach et al., 2011a; Williams et al., 2011; Wu et al., 2011a; Xu
et al., 2011b) (Rest in Figure 3B), mouse cerebellum (Melle´n
et al., 2012; Song et al., 2011), and mouse/human fontal cortex
(Lister et al., 2013). Despite their scarcity in the bulk genome,
5fC and 5caC also exhibit a tendency to accumulate within
actively transcribed gene bodies in the absence of TDG (Shen
et al., 2013; Song et al., 2013a) (Rest in Figure 3B). The exact
role of intragenic 5hmC/5fC/5caC in transcriptional regulation
is currently unclear. One possible function of intragenic 5fC/
5caC is to regulate the rate of RNA polymerase II transcription
(Kellinger et al., 2012). In mouse ESCs, 5hmC/5fC/5caC is also
more enriched at exons relative to introns, raising the possibility
that 5mC oxidation may regulate mRNA processing events such
as splicing.
Oxidized Methylcytosines at Distal cis-Regulatory
Elements
Both affinity enrichment-based and base-resolution mapping
analyses indicate that 5hmC is highly enriched at active distal-regulatory elements (Stroud et al., 2011; Yu et al., 2012), which
are marked by DNase I hypersensitivity, enhancer-associating
histone modifications (H3K4me1 and H3K27ac) (Shen et al.,
2012) and LMRs. Interestingly, base-resolution mapping indi-
cates that 5hmC is actually depleted at the binding motif of
transcription factors or CTCF insulators but enriched at immedi-
ately adjacent regions (Lister et al., 2013; Yu et al., 2012).
Furthermore, base-resolution mapping of 5mC and 5hmC during
human and mouse fontal cortex development showed that for
adult-brain-specific enhancers (active in adult brains but inactive
in fetal brains), both 5mC and 5hmC are enriched at the center
regions of fetal brains but are lost in adult brains (Lister et al.,
2013), supporting a role of TET-mediated 5mC oxidation in
enhancer activation in postnatal brains.
In mouse ESCs, 5hmC and 5fC tend to enrich at poised tissue-
specific enhancers (H3K4me1-positive, but H3K27ac-negative)
(Shen et al., 2013; Song et al., 2013a), indicating that these
poised enhancers are premarked by 5hmC/5fC for subsequent
demethylation during later development. Furthermore, 5caC (to
a lesser extent for 5fC) is preferentially accumulated at distally
located active enhancers in Tdg-depleted mouse ESCs (Shen
et al., 2013; Song et al., 2013a). For instance, 5caC is enrichedCell 156, January 16, 2014 ª2014 Elsevier Inc. 55
at a cohort of distal pluripotency TF (Oct4/Nanog/Sox2)-binding
sites in Tdg-depleted mouse ESCs (Zfp281 in Figure 3B). These
results suggest that TET/TDG-mediated active demethylation is
preferentially targeted to these active distal-regulatory elements.
DNA binding proteins are capable of inducing localized DNA
demethylation (Stadler et al., 2011), but it is currently unclear
how TET/TDG activity is recruited to these cis-regulatory ele-
ments. TET and TDG may be recruited directly by transcription
factors or coactivators (CBP/p300). Alternatively, transcription
factor binding may first facilitate promoter-enhancer interaction
via looping, which allows promoter-bound TET/TDG proteins to
access distal-regulatory elements.
Oxidized 5mC Bases as Potential Epigenetic Marks
It is known that specific protein domains exist to recognize
unmodified, hemi- or fully methylated CpG sites. For example,
unmethylated CpG sites (CG:GC) can be specifically recognized
by CXXC-domain-containing proteins (Long et al., 2013),
whereas the SRA domain in UHRF1 and methyl-CpG-binding
domains (MBD) can specifically recognize hemimethylated
(mCG:GC) and symmetrically methylated (mCG:GCm) CpG
dyads, respectively (Hashimoto et al., 2010). Besides acting as
intermediates of active DNA demethylation, growing evidence
suggests that 5hmC is relatively stable in the genome and
may potentially influence transcription by attracting or repelling
specific DNA-binding proteins. There is evidence that several
MBD proteins, including MBD3 (Yildirim et al., 2011), MeCP2
(Melle´n et al., 2012), and MBD4 (Otani et al., 2013a), may also
bind to hemi- or fully hydroxymethylated CpG sites, suggesting
that these proteins have dual binding capacity for 5mC and
5hmC. Recently, mass spectrometry-based unbiased analyses
of nuclear proteins in mouse ESCs, neural progenitor cells
(NPC), and adult brains have identified a large number of
candidate proteins bound selectively to or repelled by 5hmC-
containing oligonucleotides (Spruijt et al., 2013). While some
5hmC interacting protein candidates (e.g., WDR76, THY28)
are ubiquitously expressed, many of them are expressed in a
cell-type-specific manner. For instance, 5hmC-specific reader
protein UHRF2 and THAP11 are preferentially enriched in
NPCs and adult brains, respectively, suggesting that 5hmC
may mediate cell-type-specific functions by recruiting distinct
reader proteins.
Despite their scarcity in the genome, 5fC and 5caC possess
unique chemical groups for protein recognition, raising the
possibility that they may act as dynamic/transient epigenetic
marks (Song and He, 2013). For example, TDG and a number
of DNA repair proteins were found to specifically bind to 5fC-
and 5caC-containing DNA oligonucleotides (Spruijt et al.,
2013). Another study also identified many candidate proteins
from mouse ESC nuclear extract that specifically bind to 5fC,
including transcription factors, DNA repair proteins, and chro-
matin regulators (Iurlaro et al., 2013). However, these studies
cannot distinguish between proteins that bind directly and indi-
rectly to 5fC/5caC, and some candidates may simply bind to
formyl or carboxyl groups nonspecifically. In addition to the
possibility of acting as epigenetic marks, 5fC/5caC may
contribute to transcriptional regulation through eliciting ‘‘sched-
uled’’ DNA repair response at specific gene regulatory elements
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Biological Processes
Global erasure of 5mC is known to occur in specific stages
of mammalian development, including early preimplantation
embryos and developing germ cells. A better understanding of
the biochemical basis of DNA demethylation pathway and
emergence of new technologies for mapping various cytosine
modifications have opened new avenues to study the role of
DNA demethylation in these biological processes. Intriguingly,
the broad expression patterns of TET enzymes and other
components of active DNA demethylation pathway in somatic
tissues such as brains imply that dynamic DNA demethylation
may be more prevalent than previously thought. Below, we
review recent advances in our understanding on biological func-
tions of DNA demethylation in various biological and patholog-
ical settings.
DNA Demethylation Dynamics in Preimplantation
Development
After the sperm fertilizes the oocyte and before two pronuclei
merge, the paternal genome goes through a complex epigenetic
remodeling process that includes global erasure of DNA methyl-
ation. The sperm undergoes a rapid loss of 5mCbefore the onset
of first DNA replication as measured by immunostaining and
locus-specific bisulfite sequencing (Mayer et al., 2000; Oswald
et al., 2000); by contrast, the maternal genome is not affected
in one-cell zygotes, but become gradually demethylated during
subsequent cleavage divisions. Recent studies indicate that
the loss of paternal DNA methylation coincides with a rapid in-
crease in 5hmC (Inoue and Zhang, 2011; Iqbal et al., 2011; Wos-
sidlo et al., 2011) and 5fC/5caC (Inoue et al., 2011), suggesting
that TET-mediated 5mC oxidation is involved in the erasure of
5mC. Knockdown or deletion of TET3, the only 5mC oxidase
present at this stage, abolished the loss of 5mC and 5hmC
generation in the male pronucleus (Gu et al., 2011; Wossidlo
et al., 2011). Tet3-deficient oocytes fertilized with wild-type
sperms can develop normally to blastocysts, but many of these
heterozygous embryos exhibit developmental failure (Gu et al.,
2011), indicating that TET3-mediated rapid and specific oxida-
tion of 5mC from paternal genome is biologically relevant. It
will be interesting to identify which regions in the paternal
genome are preferentially targeted by TET3 and to determine
why 5mC oxidation of paternal genome is functionally important
for early embryogenesis.
The striking asymmetry of epigenetic reprogramming between
paternal and maternal genomes in one-cell zygotes can poten-
tially be achieved through either specific targeting of TET3 to
paternal genome or active protection of maternal genome from
TET3-mediated 5mC oxidation. A recent study indicates that
Stella (also known as PGC7 or Dppa3), a maternal factor essen-
tial for early development (Payer et al., 2003), is recruited to
oocyte-derived genome by dimethylation of Lys9 on H3
(H3K9me2), a histone mark that is preferentially enriched on
maternal chromatin (Nakamura et al., 2012). In the absence of
Stella, TET3 is localized to both paternal and maternal genomes
(Nakamura et al., 2012; Wossidlo et al., 2011), and the maternal
genome also undergoes 5mC oxidation (Nakamura et al., 2007;
Nakamura et al., 2012). Locus-specific bisulfite sequencing anal-
ysis further demonstrated that Stella is required for protecting a
Figure 4. DNA Methylation Dynamics dur-
ing Mouse Preimplantation Development
(A) Dynamic changes in cytosine modifications
and relevant enzymes during preimplantation
development. Immediately after fertilization,
paternal 5mC is rapidly oxidized to 5hmC/5fC/
5caC by TET3 proteins. In early preimplantation
embryos, oocyte-derived DNMT1o is largely
excluded from nucleus (dash line) and conse-
quently maintenance methylation is inefficient.
Oxidized 5mC bases in the paternal genome and
5mC in the maternal genome are therefore
passively diluted. The global 5mC level reaches
the lowest point around blastocyst stage (E3.5).
After implantation, DNA methylation pattern is re-
established by DNMT3A/3B in inner cell mass
(ICM) cells, but not in trophectoderm (TE) cells.
The genome of ground-state ESC (2i-condition) is
hypomethylated (5mC: 1% of all C) and is more
similar to the methylome of preimplantation ICM
cells, whereas primed ESCs (serum) possess a
methylome (5mC: 4% of all C) that recapitulates
overall methylation pattern in epiblast cells.
(B) Developmental stage-specific usage of the
cyclic cytosine-modifying enzymatic cascade
during early embryonic development. Upon fertil-
ization, oocyte-derived TET3 proteins specifically
localize to paternal nucleus and convert sperm-
derived 5mC to 5hmC/5fC/5caC. DNA replication
drives passive loss of 5hmC/5fC/5caC in the
paternal genome and 5mC in the maternal
genome (left). In primed ESCs and cells during
ICM-to-epiblast transition in vivo, all enzymes of
the cytosine-modifying cascade are expressed at
relatively high levels. Dnmt3A/3B/3L and DNMT1/
UHRF1 establish and maintain 5mC patterns. At
some genomic regions (e.g., active enhancers and
bivalent promoters) in these cells, TET1/2 oxidize
5mC to 5hmC/5fC/5caC, and TDG/BER excises
5fC/5caC to regenerate unmodified cytosine.few imprinting control regions (ICRs) in the paternal genome (Na-
kamura et al., 2007), which are also associated with H3K9me2
(Nakamura et al., 2012). However, the exact mechanism by
which Stella inhibits TET3 function is unknown.
After paternal and maternal pronuclei fuse, bulk 5hmC/5fC/
5caC signals in sperm-derived chromosomes (AM-PD in
Figure 2A) and 5mC in oocyte-derived chromosomes (PD in
Figure 2A) are lost in a replication-dependent manner (Inoue
et al., 2011; Inoue and Zhang, 2011; Mayer et al., 2000). The
passive dilution of maternal 5mC is believed to be ensured by
active exclusion of DNMT1o (an oocyte-derived variant of
DNMT1) and likely UHRF1 from the nucleus in early embryos
(Seisenberger et al., 2013) (Figure 4A). Despite this wave of
global DNA demethylation, a subset of maternally derived meth-
ylated CpG-rich sequences, including many maternal ICRs and
some retroviral repeats such as the intracisternal A particle
(IAP) type, remain fully or partially methylated (Lane et al.,Cell 152003; Smallwood et al., 2011; Smith
et al., 2012). Recent evidence suggests
that maintenance of 5mC at ICRs is
perhaps conferred through targeting
DNMT1 and/or DNMT3A to these
regions by zinc finger transcription factor
ZFP57 and its partner, KAP1 (also knownas TRIM28) (Li et al., 2008; Messerschmidt et al., 2012; Quenne-
ville et al., 2011). In line with the role of this complex in mainte-
nance of 5mC at imprinting loci, ZFP57 prefers to bind to its
target sequence (TGCmCGC, present in all known murine ICRs)
when it is methylated, but has reduced binding affinity when its
target sequence is unmodified or hydroxymethylated DNA (Liu
et al., 2012).
If inefficient maintenance of DNA methylation is a major driver
for the genome-wide erasure of 5mC in early embryos
(Figure 4B), why the paternal genome needs to be oxidized first?
One possible reason might be to rapidly equalize 5mC levels of
the two parental genomes as the CpG methylation level differs
significantly between sperms (90%) and oocytes (40%)
before fertilization (Kobayashi et al., 2012). Thus, oxidized 5mC
bases in paternal genome may accelerate the demethylation
process of paternal genome. 5fC and 5caC generated from fur-
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excision repair pathway (Inoue et al., 2011), and there is some
evidence supporting a role of BER in paternal genome
demethylation (Hajkova et al., 2010). However, bulk 5fC and
5caC signals in the paternal genome remain detectable by
immunostaining in 4-cell stage and also exhibit replication-
dependent dilution (Inoue et al., 2011), suggesting that 5fC/
5caC are not rapidly excised. In support of this view, single-
cell RNA-seq analysis suggests that the Tdg gene is expressed
at extremely low levels in oocytes and during preimplantation
development (Tang et al., 2011) (Figure 4A), indicating that
TDG may only play a limited role in paternal genome demethyla-
tion (e.g., locus-specific demethylation). Alternatively, after DNA
replication, CpG sites with hemimodified state (XG:GC, X = hC,
fC, caC) in the paternal genome may be more resistant to enzy-
matic activity of maternal DNMT3A or residual DNMT1o in the
nucleus than hemimethylated CpG sites (mCG:GC), thereby
ensuring more efficient paternal demethylation.
Overall, DNA demethylation in early embryos is a highly
orchestrated process, requiring both active and passive deme-
thylation. In addition, specific factors, such as Stella and
ZFP57/KAP1, may protect 5mC patterns at selective loci (e.g.,
ICRs) from either active (TET3-mediated 5mC oxidation) or pas-
sive (inefficient methylation maintenance) demethylation. Inter-
estingly, in contrast to the situation in mice, recent methylome
analyses in zebrafish suggest that paternal methylation pattern
is maintained during early embryogenesis; instead, the relatively
hypomethylated maternal genome is progressively reprog-
rammed to a pattern similar to that of the sperm methylome
(Jiang et al., 2013; Potok et al., 2013). Furthermore, 5mC oxida-
tion is not detected during zebrafish early embryo development
(Jiang et al., 2013). Thus, 5mC oxidation-mediated paternal
genome demethylation seems to be a unique regulatory mecha-
nism for mammalian embryogenesis. The evolutionary signifi-
cance of this mechanism awaits further investigation.
DNA Demethylation in Pluripotent Stem Cells and
Reprogramming
As the zygote develops into the blastocyst (E3.5), the genome of
inner cell mass (ICM) cells becomes hypomethylated (21%
CpG methylation) as compared to sperm (90%) or oocyte
(40%) methylome after replication-dependent dilution of
maternal 5mC and paternal 5hmC/5fC/5caC (Kobayashi et al.,
2012). Thereafter, DNMT3A/3B mediated de novo methylation
takes places during the developmental transition from blastocyst
to epiblast stage (70%) by E6.5 (Seisenberger et al., 2012; Smith
et al., 2012) (Figure 4A). ESCs are initially derived from the ICM of
blastocysts, and these pluripotent stem cells possess unique
properties of self-renewing while maintaining potential to
differentiate into any somatic cell lineages (Hanna et al., 2010).
Traditionally, mouse ESCs are cultured in serum supplemented
with leukemia inhibitory factor (LIF) and their methylomes
resemble those of somatic cells (70% CpG methylation). Mouse
ESCs grown in serum exhibit greater heterogeneity and consist
of at least two distinguishable populations, one with a transcrip-
tome similar to the naive ICM-like state and the other similar to
the primed epibalst-like state.
Inhibition of the mitogen-activated protein (MAPK) pathway
and the glycogen synthase kinase (GSK3) pathway, via two
kinase inhibitors (PD0325901 for MAPK and CHIR99021 for58 Cell 156, January 16, 2014 ª2014 Elsevier Inc.GSK3, known as 2i condition), is sufficient to maintain mouse
ESCs in the naive ICM-like state (Ying et al., 2008). Mouse
ESCs grown in the 2i condition appear to be a homogeneous
population that has a transcriptome and histone modification
profile distinct from that of serum-grown mouse ESCs (Marks
et al., 2012). Using mass spectrometry or whole-genome BS-
seq (WGBS), recent studies showed that 2i-grown mouse
ESCs adopt a globally hypomethylated genome recapitulating
that of ICM cells in vivo (Ficz et al., 2013; Habibi et al., 2013;
Leitch et al., 2013). Strikingly, switching from serum to 2i condi-
tion induces genome-wide DNA demethylation in mouse ESCs,
which is on a scale and pattern similar to the early embryos.
While the maintenance methylation system (DNMT1/UHRF1)
and TET1/2 are expressed at comparable levels between ground
state (2i) and primed state (serum) mouse ESCs, PR-domain-
containing 14 (PRDM14) is upregulated in 2i-grown mouse
ESCs and mediates rapid transcriptional downregulation of the
de novo DNA methylation machinery (DNMT3A/3B/3L) (Yamaji
et al., 2013). Available evidence suggests that global demethyla-
tion during the serum-to-2i transition is primarily induced by the
downregulation of DNMT3A/3B/3L and TET1/2-mediated tran-
sient 5mC oxidation (Blaschke et al., 2013; Ficz et al., 2013;
Habibi et al., 2013). Overall, globally hypomethylated genomes
observed in ground state mouse ESCs (2i-condition) closely
resemble the methylome of ICM cells in preimplantation blasto-
cysts, whereas serum-grown mouse ESCs have a hypermethy-
lated genome similar to that of postimplantation embryos and
somatic cells.
In serum-grown mouse ESCs, all major components of the
cytosine-modifying cascade (DNMT, TET, TDG, and BER
proteins) are expressed (Figure 4B). Thus, ESCs in primed state
provide a model system for understanding DNA demethylation
dynamics and its regulatory mechanisms. Single or combined
depletion of Tet1 and Tet2 in mouse ESCs, by short-hairpin
RNA (shRNA)-mediated knockdown or genetic inactivation,
produced variable in vitro phenotypes (Dawlaty et al., 2013;
Dawlaty et al., 2011; Ficz et al., 2011; Freudenberg et al., 2012;
Ito et al., 2010; Koh et al., 2011; Williams et al., 2011). Multiple
studies confirmed that depletion of TET1 alone or in combination
with TET2 skews in vitro differentiation toward trophectoderm
and primitive endoderm, and teratomas derived from Tet1/
or Tet1/2/ ESCs are enriched for trophoblast cells. In support
of a role of TET1 in regulating early lineage commitment, TET1
negatively regulates the expression of key regulators of trophec-
toderm lineage, such asCdx2 and Eomes, possibly by facilitating
binding of repressor complexes to target gene promoters
(Williams et al., 2011; Wu et al., 2011b). However, there are con-
flicting results concerning the role of TET1 in the maintenance of
mouse ESCs (Dawlaty et al., 2011; Freudenberg et al., 2012; Ito
et al., 2010; Williams et al., 2011; Wu and Zhang, 2011b). The
use of different cell lines and culturing conditions may contribute
to these discrepancies, although potential off-target effects
of specific shRNAs cannot be ruled out. Because all these
studies focused on serum-grown ESCs, fluctuating epigenetic
state associated with this heterogeneous ESC population may
also contribute to the variable phenotype in Tet1-depleted
mouse ESCs. Overall, current data indicate that, despite the
presence of relatively high level of TET1/2 proteins and oxidized
Figure 5. Global Reprogramming of DNA Methylation Patterns during Early PGC Development
(A)Dynamic changes in cytosine modifications and expression levels of relevant enzymes during early stage of mouse PGC development. Global erasure of DNA
methylation in developing PGCs goes through two phases. In the first phase (E7.25 to E9.0), both de novo and maintenance methylation machineries are
functionally impaired due to the repression of DNMT3A/3B/3L and UHRF1. There is also evidence that remaining UHRF1 is excluded from nucleus (dash line).
Thus, loss of bulk genomic DNA methylation (solid line, inherited from epiblast cell stage) takes place in a replication-dependent manner in phase 1. However, a
portion of the genome (dash line) including ICRs and germline-specific genes are partially or fully protected from the first wave of passive demethylation. In the
second phase (E9.5 to E12.0), TET1 (possibly TET2) are upregulated and oxidize remaining 5mC to 5hmC.
(B)Developmental stage-specific usage of the cytosine-modifying enzymatic cascade during early stage of PGC development. In phase 1 of PGC demethylation,
bulk of the genome undergoes global demethylation in the absence of de novo andmaintenance DNAmethylation. In phase 2, TET1/2 proteins oxidize remaining
5mC at late demethylating loci. Replication-dependent loss of 5hmC completes the global demethylation process. 5fC/5caC is not specifically enriched in
developing PGCs as compared to surrounding somatic cells, so they may be actively excised by TDG/BER pathway that is present in PGCs.methylcytosines in ESCs, TET enzymes are largely dispensable
for ESC maintenance but may play a role in guiding ESCs to
properly differentiate into specific lineages and/or regulating
later development of the embryos. Indeed, while Tet1/ and
Tet2/ single-mutant mice are viable, roughly half of
Tet1/Tet2/ double knockout (DKO) mice from intercrossing
double-heterozygous animals die perinatally with severe devel-
opmental abnormalities, indicating a role of TET1/2 proteins in
regulating embryonic development (Dawlaty et al., 2013). The
partially penetrant perinatal lethality of TET1/2 DKO mutants
suggests TET3 may compensate for the loss of TET1/2 during
development. In line with this notion, all Tet3/ single mutants
die perinatally (Gu et al., 2011).
While additional studies are needed to clarify the exact
function of TET proteins in mouse ESCs and embryonic devel-
opment, recent studies support a role for TET enzymes in
transcription factor (Oct4/Klf4/Sox2/c-Myc, referred to as
OKSM)-mediated reprogramming of somatic cells to induced
pluripotent stem cells (iPSCs) (Hanna et al., 2010). One study
showed that TET2 is recruited to the Nanog and Esrrb loci
(both are pluripotency-related TFs) to facilitate their transcription
in the early stage of reprogramming (Doege et al., 2012). In addi-
tion, TET1 and TET2 may interact with Nanog protein and
promote iPSC generation in a TET catalytic activity-dependent
manner (Costa et al., 2013). More strikingly, TET1 overexpres-
sion not only promotes transcriptional reactivation of Oct4 but
can also replace Oct4 in the reprogramming OKSM cocktail
(Gao et al., 2013). A recent study also implicates a role of vitamin
C in modulating TET functions during iPSC generation (Chen
et al., 2013a).
In addition to TET proteins, TDG may also play a role in stem
cell functions and embryonic development. TDG is broadlyexpressed during early development and in adult tissues. Deple-
tion of Tdg by shRNA or genetic inactivation inmouse ESCs does
not cause any discernible phenotype in ESC proliferation or early
differentiation (Corta´zar et al., 2011; Shen et al., 2013; Song
et al., 2013a), suggesting that TDG may regulate later steps of
embryonic development. Indeed, Tdg-deficiency in mice causes
widespread development deficits and embryonic lethality (Cor-
ta´zar et al., 2011; Cortellino et al., 2011). Further studies are
needed to clarify the exact mechanism by which TDG contrib-
utes to developmental gene regulation.
DNA Demethylation Dynamics during Germ Cell
Development
Around E6.5, a subset of posterior epiblast cells (40 cells) are
instructed by specific factors such as BLIMP1 (also known as
PRDM1) and PRDM14 to become PGCs (Sasaki and Matsui,
2008). These committed PGCs suppress somatic transcriptional
program and reactivate expression of pluripotency-associated
factors. Around E7.5, PGCs start to migrate through the hindgut
to the developing gonad, where they colonize by E10.5 to initiate
epigenetic reprogramming (Figure 5A) (Saitou et al., 2012). Early
PGCs (E7.25) are thought to inherit a methylation pattern similar
to that of epiblast cells (70% CpG methylation), but they
undergo global erasure of DNA methylation and become nearly
completely demethylated in gonadal PGCs around E13.5 (7%–
14%) (Seisenberger et al., 2012).
Recent genome-wide DNA methylation studies suggest that
global erasure of DNA methylation in PGCs takes place in two
distinct phases (Seisenberger et al., 2012; Vincent et al., 2013).
The first phase of demethylatioin (phase 1 in Figure 5A) occurs
before or during PGC migration to genital ridge and appears
to primarily involve replication-dependent passive dilution of
5mC. Upon PGC specification (E7.25), all components of deCell 156, January 16, 2014 ª2014 Elsevier Inc. 59
novo methylation systems are transcriptionally downregulated
(Kagiwada et al., 2013), possibly due to PRDM14-mediated
repression. UHRF1 is also acutely downregulated in PGCs (Kagi-
wada et al., 2013; Seisenberger et al., 2012), which prevents
localization of DNMT1 to replication foci. In the absence of
efficient de novo and maintenance methylation, global erasure
of DNA methylation occurs indiscriminately at nearly all genomic
features (promoters, exons, introns, repeats and intergenic re-
gions) in early replicating PGCs. By E9.5, the overall CpGmethyl-
ation level reduces to30% in PGCs (Seisenberger et al., 2012).
In line with this model, recent evidence suggests that TET pro-
teins are largely dispensable for the initial global DNA demethy-
lation (Figure 5B). Mass spectrometry and WGBS analysis of
PGC-like cells differentiated in vitro from Tet1/2-depletedmouse
ESCs (shRNA-mediated depletion of Tet1 in Tet2/ cells) indi-
cate that global loss of 5mC in early PGCs still occurs in the
absence of TET1/2 (Vincent et al., 2013). Furthermore, WGBS
analysis of Tet1 mutant PGCs derived from gene-trap female
mice indicates that Tet1-deficiency does not affect global deme-
thylation (Yamaguchi et al., 2012).
Methylation levels at some genomic regions, including ICRs,
CpG-rich promoters of germ-cell-specific genes, CGIs on X
chromosome genes, and specific type of repeats (e.g., IAPs),
are largely maintained during the first phase of global demethy-
lation in PGCs. Demethylation of these sequences is only
completed once PGCs settle in gonad and is most likely initiated
by TET1/2-mediated 5mC oxidation (phase 2 in Figure 5A).
Expression of TET1/2 is upregulated in gonadal PGCs (relative
to early PGCs and surround somatic cells) (Hackett et al.,
2013; Yamaguchi et al., 2012), and antibody-based genome-
wide mapping of 5mC and 5hmC in PGCs indicates that 5mC
is oxidized to 5hmC at many late demethylating loci between
E9.5 to E11.5 (Hackett et al., 2013). Time-course analysis
suggests that both 5mC and 5hmC are lost at a rate consistent
with replication-dependent dilution during this period (Hackett
et al., 2013; Kagiwada et al., 2013). Given that TDG and BER
components are expressed throughout the PGC development
(Kagiwada et al., 2013) (Figure 5B), it is likely that TDG/BER
may play a role in removing 5fC/5caC at specific loci during
phase 2. Integrated genomic analysis showed that TET1 is
specifically required for promoter demethylation and transcrip-
tional activation of germline-specific genes such as meiosis-
related genes (e.g., Mae1, Sycp1, and Sycp3) in developing
female PGCs (Yamaguchi et al., 2012). The locus-specific deme-
thylation at meiotic gene promoters by TET1 in female PGCs is
biologically important, as half of the Tet1-deficient female gam-
etes exhibits a defect in meiotic synapsis and become develop-
mentally arrested later (Yamaguchi et al., 2012).
Conversion of 5mC to 5hmC at ICRs in late PGCs suggests
that TET proteins are also required for the complete 5mC erasure
at parental imprints (Hackett et al., 2013). Analysis of methylated
ICRs of somatic cells fused with embryonic germ cells (EGCs)
suggests that TET1 can induce 5mC oxidation specifically at
ICRs and mediate eventual erasure of imprints in this in vitro
system (Piccolo et al., 2013). Locus-specific methylation anal-
ysis in progenies of Tet1/Tet2/ mice revealed aberrant
methylation pattern at some ICRs, further supporting a mecha-
nistic link between TET proteins and erasure of parental imprints60 Cell 156, January 16, 2014 ª2014 Elsevier Inc.in PGCs (Dawlaty et al., 2013). More definitive evidence comes
from analysis of progenies derived from crossing Tet1/ male
with wild-type female (Yamaguchi et al., 2013). Despite their
identical genotype, these heterozygous progenies exhibit a num-
ber of variable phenotypes including placental, fetal and post-
natal growth defects, and early embryonic lethality. Several lines
of evidence suggest that these developmental defects can be
largely explained by the Tet1-deficiency induced epigenetic
dysregulation of imprinted genes in PGCs. First, many dys-
regulated imprinting genes, such as Peg10 and Peg3, exhibit
aberrant hypermethylation in the paternal allele of differential
methylated regions (DMRs) in progenies of Tet1/ male. Sec-
ond, RNA-seq analysis reveals extensive dysregulation of
imprinted genes in these heterozygous progenies. Lastly,
reduced representation bisulfite sequencing (RRBS) analysis of
E13.5 PGCs and sperms of Tet1/male mice reveals that aber-
rantly hypermethylated ICRs observed in Tet1/ sperms can be
traced back to PGCs. Overall, these data suggest that TET1
plays a critical role in resetting parental origin-specific genomic
imprinting in PGCs by facilitating the complete erasure of
methylation at ICRs (phase 2 in Figure 5). Curiously, it is currently
unclear why and how late demethylating loci such as promoters
of meiotic genes and ICRs of imprinting genes are protected
from the initial phase of global demethylation in early PGCs
(phase 1 in Figure 5).
In summary, both passive and active demethylation mecha-
nisms are critical to complete genome-wide erasure of DNA
methylation in developing PGCs. This is reminiscent of global
demethylation in early embryos. In both cases, passive dilution
is facilitated by inefficient maintenance methylation systems
(exclusion of Dnmt1o in early embryos and transcriptional
repression of Uhrf1 in developing PGCs). Meanwhile, 5mC
oxidation by TET3 in zygotes and TET1 (potentially TET2) in
PGCs is indispensable for achieving efficient and complete
erasure of 5mC in paternal genome of early embryos and late
demethylating loci (e.g., meiotic genes and ICRs) in PGCs,
respectively.
Role of DNA Demethylation in Neural Development
The development of mammalian brain is a spatiotemporally
orchestrated process that requires precisely controlled gene
regulatory program to generate diverse, functionally distinct
populations of neurons and glia. Inactivation of DNMTs in the
nervous system results in neurodevelopmental deficits and
impaired neuronal functions (Fan et al., 2001; Fan et al.,
2005; Feng et al., 2010a; LaPlant et al., 2010; Nguyen et al.,
2007; Wu et al., 2010), suggesting that precise control of
DNA methylation pattern is required for proper brain develop-
ment and maturation. Interestingly, distinct parts of mammalian
brains, including frontal cortex (Lister et al., 2013), hippocam-
pus (Mu¨nzel et al., 2010), and cerebellum (Song et al., 2011;
Szulwach et al., 2011b), all exhibit age-dependent acquisition
of 5hmC (e.g., 0.2% of cytosines in fetal cortex versus 0.9%
of cytosines in adult cortex) (Lister et al., 2013). In fact, the
genome of mature neurons in adult central nervous system
contains the highest level of 5hmC of any mammalian cell-
type (40% as abundant as 5mC in Purkinje neurons in
cerebellum) (Kriaucionis and Heintz, 2009). These observations
indicate that 5mC oxidation and potentially DNA demethylation
may be functionally important for neuronal differentiation and
maturation processes.
All three Tet genes are expressed at detectable levels in devel-
opingmousebrains (Hahnet al., 2013;Szwagierczak et al., 2010).
In embryonic cortex, an increase in expression levels of Tet2 and
Tet3 is observedwhen the Nestin-positive neural progenitor cells
(NPCs) differentiate into Tubb3-expressing neurons, coinciding
with an elevation of 5hmC level during neuronal differentiation
(Hahn et al., 2013). Knockdown of Tet2/3 in developing embry-
onic cortex via in utero electroporation results in neuronal
differentiation deficits; in contrast, overexpression of Tet2/3
seems to promote embryonic cortical neurogenesis (Hahn
et al., 2013). In addition, depletion of tet3 in Xenopus (X. laevis)
embryos by antisense morpholinos causes defects in early eye
and neural development. Interestingly, intact CXXC domain and
catalytic activity of TET3 protein are both essential for its role in
target gene regulation and normal head development (Xu et al.,
2012). Thus, these results support a conserved role of specific
TET proteins in regulating early stages of brain development.
Growing evidence suggests that TET proteins may also regu-
late adult brain functions. While Tet1/mice have no detectable
defects in embryonic development, a recent study demonstrates
that TET1 may promote adult hippocampal neurogenesis by
regulating neural progenitor proliferation and Tet1-deficiency
may cause defects in spatial learning as well as short-term
memory (Zhang et al., 2013). Analysis of DNA methylation by
RRBS and gene expression in Tet1-deficient NPCs isolated
from adult dentate gyrus (DG) of hippocampus identified a
cohort of genes that become promoter hypermethylated and
downregulated in the absence of TET1(Zhang et al., 2013).
Another study of adult Tet1/ mice revealed that multiple
neuronal activity-regulated genes, including Npas4, c-Fos, and
Arc, are transcriptionally downregulated, and promoter of
Npas4 becomes hypermethylated in absence of TET1 (Rudenko
et al., 2013). This study also demonstrated that Tet1/mice are
associated with abnormal hippocampal long-term depression
(LTD) and impaired memory extinction. Interestingly, viral-medi-
ated overexpression of TET1 or a catalytically inactive form of
TET1 in adult hippocampus resulted in transcriptional up-
regulation of several memory-associated genes and impaired
contextual fear memory (Kaas et al., 2013), suggesting a 5mC
oxidase-independent role of TET1 in adult brains. Given that
TET2 and TET3 are also expressed in adult mouse brains, it
will be interesting to examine the overlapping and distinct func-
tion of different TET proteins in adult brains.
The high abundance of 5hmC in adult brains raises the possi-
bility that 5hmC may act as an epigenetic mark. Indeed, current
evidence suggests that 5hmC may recruit MeCP2 (Melle´n et al.,
2012) and other putative binding protein candidates (Spruijt
et al., 2013) to facilitate transcription in postnatal brains. Interest-
ingly, a Rett syndrome mutation, R133C, preferentially disrupts
the ability of MeCP2 to bind to 5hmC, but not 5mC (Melle´n
et al., 2012), implicating impairment of 5hmC binding of
MeCP2 in this debilitating autism spectrum disorder. Compara-
tive analysis of 5mC, 5hmC and gene expression in specific cell
types in cerebellum or olfactory sensory neurons suggest that
enrichment of 5hmC and depletion of 5mC within intragenic
regions positively correlate with transcription and chromatinaccessibility (Colquitt et al., 2013; Melle´n et al., 2012). However,
the functional significance of the interplay between 5hmC and its
potential binding proteins remains unclear.
While most studies focused on 5mC in CpG context, non-CpG
methylation is relatively prevalent in adult mouse brains (Xie
et al., 2012). Recently, a comprehensive base-resolution ana-
lyses of 5mC and 5hmC in mammalian frontal cortex in both fetal
and adult stages indicate that non-CpG methylation (mCH) and
CpG hydroxymethylation (hCG) drastically build up in cortical
neurons after birth (Lister et al., 2013), coinciding with the peak
of synaptogenesis and synaptic pruning in the cortex. Intrigu-
ingly, this study demonstrated that mCH could become a domi-
nant form of cytosine modifications in adult brains, accounting
for 53% in adult human cortical neuronal genome. Furthermore,
the genomic positions of mCH in adult brains are highly
conserved between individuals, indicating a precisely controlled
process catalyzing non-CpG methylation in adult brain. Current
evidence suggests that the developmental acquisition of
neuronal mCH is mediated by DNMT3A, whose expression is
transiently spiked during the same period. In mature neurons,
intragenic mCH is preferentially enriched at inactive nonneuronal
lineage-specific genes, indicating a role in negative regulation of
the associated transcripts. By contrast, genic hCG is positively
correlated with gene expression levels. In addition to the 5mC/
5hmC dynamics detected in genic regions, distal cis-regulatory
regions are also associated with developmental change in
cytosine modification states. In fetal brains, hCG and mCG are
preferentially enriched at a large cohort of poised distal-regula-
tory regions that are subsequently demethylated (converting to
unmodified CG) and activated in the adult brain. Tet2-deficiency
partially blocks the demethylation process at these hCG-marked
poised regulatory elements. However, it is currently unclear
whether this TET-mediated demethylation process at poised
neuronal enhancers primarily occurs in proliferating neuronal
progenitors or postmitotic neurons. Publically accessible RNA-
seq data sets indicate that Tdg gene is expressed in both fetal
and adult mouse cortex, suggesting that TET/TDG-active deme-
thylation may take place in both progenitors and neurons.
Further studies are needed to reveal the mechanism and biolog-
ical significance of widespread methylome reconfiguration in the
neuronal genome during the maturation process of brain.
DNA Demethylation and Cancer
Aberrant DNA methylation is one of the hallmarks associated
with cancer cells (Baylin and Jones, 2011; Esteller, 2007).
Growing evidence suggests that impairment in TET-mediated
DNA demethylation may contribute to tumorigenesis (Cimmino
et al., 2011; Wu and Zhang, 2011a). The initial evidence impli-
cating TET proteins in cancer development came from the iden-
tification of human TET1 as a rare fusion partner of MLL in
patients with acute myeloid leukemia (AML) (Ono et al., 2002).
Subsequent studies reveal a link between recurrent mutations
in the TET2 gene and myelodysplastic disorders (Delhommeau
et al., 2009; Langemeijer et al., 2009). Mouse genetic studies
have demonstrated that Tet2-deficiency causes enhanced
self-renew of hematopoietic stem cells (Ko et al., 2011; Li
et al., 2011; Moran-Crusio et al., 2011; Quivoron et al., 2011),
supporting a role of TET2 as tumor suppressor for leukemia.
TET2 mutations associated with myeloid malignancies impairCell 156, January 16, 2014 ª2014 Elsevier Inc. 61
enzymatic activity and cause consistent loss of 5hmC in patient
bone marrows (Ko et al., 2010).
Interestingly, TET2 mutations are found to be mutually exclu-
sive with neomorphic mutations in IDH1/2 (R132 of IDH1 and
R140/172 of IDH2) in AML (Dang et al., 2009; Ward et al., 2010).
Wild-type IDH1/2 converts isocitrate to a-KG, whereas mutant
IDH enzymes produce 2-hydroxyglutarate (2-HG), an oncometa-
bolite that competitively inhibit many a-KG-dependent dioxyge-
nases, including TET proteins (Figueroa et al., 2010; Xu et al.,
2011a). Similarly, inactivation mutations in SDH and FH, which
have been identified in a subset of cancers, lead tomarked accu-
mulation of succinate and fumarate, both of which can inhibit
a-KG-dependent dioxygenases (Xiao et al., 2012). Thus, muta-
tions in these TCA cycle enzymes may lead to inactivation of
TET proteins and alteration of methylome in cancer cells.
Recent studies suggest that transcriptional downregulation of
all three TET genes and IDH1/2 is observed in many solid can-
cers that are not known to be associated with mutations in these
enzymes, and global loss of 5hmC may be broadly used as a
diagnostic biomarker for human melanoma, breast, liver, lung
pancreatic and prostate cancers (Hsu et al., 2012; Lian et al.,
2012; Yang et al., 2013). Overexpression of oncogenic miRNAs
that target TET mRNAs may be one possible mechanism to
downregulate TET proteins and 5hmC levels (Song et al.,
2013c). In summary, multiple mechanisms may cause inactiva-
tion of TET-mediated 5mC oxidation, but relevant molecular
targets of TET proteins that are causally linked to cancer devel-
opment are not systematically investigated. It is also unclear
whether TDG and 5fC/5caC may play a role in cancer.Conclusion and Perspective
The discovery of oxidative modification of 5mC and related
repair mechanism has provided a new perspective on how her-
itable DNA methylation pattern may be dynamically regulated
in the mammalian genome. The realization that epigenetic infor-
mation can be reversibly ‘‘written’’ and ‘‘erased’’ on mammalian
DNA through the cyclic cytosine-modifying cascade raises new
mechanistic and biological questions: Which 5-methylcytosines
in the genome are selectively targeted by TET and TDG-medi-
ated demethylation activity? Can oxidized 5mC bases (5hmC/
5fC/5caC) act as epigenetic marks by recruiting or repelling
specific reader proteins? How does targeted excision repair of
5fC/5caC at distal cis-regulatory elements contribute to gene
regulation? How is TET-mediated active erasure of 5mC regu-
lated in response to developmental signaling, environmental
stimuli and changes in metabolic states? How does this dynamic
epigenetic regulatory process functionally contribute to develop-
ment and diseases in vivo? New technologies such as TAL effec-
tors and CRISPR/Cas9 that allow manipulation of the epigenetic
state of cytosine modification at specific loci (Maeder et al.,
2013) as well as base-resolution mapping of all five cytosine
modification states promise to advance this exciting field sub-
stantially in the coming years.
ACKNOWLEDGMENTS
We thank members of the Zhang Lab for their comments on the manuscript.
We apologize to colleagues whose work cannot be cited owing to space con-62 Cell 156, January 16, 2014 ª2014 Elsevier Inc.strains. This work was supported by NIH grants GM68804 and U01DK089565
(to Y.Z.). H.W. is supported by a postdoctoral fellowship from the Jane Coffin
Childs Memorial Fund for Medical Research. Y.Z. is an Investigator of the
Howard Hughes Medical Institute.REFERENCES
Barreto, G., Scha¨fer, A., Marhold, J., Stach, D., Swaminathan, S.K., Handa, V.,
Do¨derlein, G., Maltry, N., Wu, W., Lyko, F., and Niehrs, C. (2007). Gadd45a
promotes epigenetic gene activation by repair-mediated DNA demethylation.
Nature 445, 671–675.
Baylin, S.B., and Jones, P.A. (2011). A decade of exploring the cancer epige-
nome - biological and translational implications. Nat. Rev. Cancer 11,
726–734.
Bennett, M.T., Rodgers, M.T., Hebert, A.S., Ruslander, L.E., Eisele, L., and
Drohat, A.C. (2006). Specificity of human thymine DNA glycosylase depends
on N-glycosidic bond stability. J. Am. Chem. Soc. 128, 12510–12519.
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry,
B., Meissner, A., Wernig, M., Plath, K., et al. (2006). A bivalent chromatin struc-
ture marks key developmental genes in embryonic stem cells. Cell 125,
315–326.
Bhutani, N., Brady, J.J., Damian, M., Sacco, A., Corbel, S.Y., and Blau, H.M.
(2010). Reprogramming towards pluripotency requires AID-dependent DNA
demethylation. Nature 463, 1042–1047.
Bird, A. (2002). DNAmethylation patterns and epigenetic memory. Genes Dev.
16, 6–21.
Blaschke, K., Ebata, K.T., Karimi, M.M., Zepeda-Martı´nez, J.A., Goyal, P.,
Mahapatra, S., Tam, A., Laird, D.J., Hirst, M., Rao, A., et al. (2013). Vitamin
C induces Tet-dependent DNA demethylation and a blastocyst-like state in
ES cells. Nature 500, 222–226.
Booth, M.J., Branco, M.R., Ficz, G., Oxley, D., Krueger, F., Reik, W., and
Balasubramanian, S. (2012). Quantitative sequencing of 5-methylcytosine
and 5-hydroxymethylcytosine at single-base resolution. Science 336,
934–937.
Borst, P., and Sabatini, R. (2008). Base J: discovery, biosynthesis, and
possible functions. Annu. Rev. Microbiol. 62, 235–251.
Bostick, M., Kim, J.K., Este`ve, P.O., Clark, A., Pradhan, S., and Jacobsen, S.E.
(2007). UHRF1 plays a role inmaintaining DNAmethylation inmammalian cells.
Science 317, 1760–1764.
Bransteitter, R., Pham, P., Scharff, M.D., and Goodman, M.F. (2003). Activa-
tion-induced cytidine deaminase deaminates deoxycytidine on single-
stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA
100, 4102–4107.
Chen, T., Ueda, Y., Dodge, J.E., Wang, Z., and Li, E. (2003). Establishment and
maintenance of genomic methylation patterns in mouse embryonic stem cells
by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23, 5594–5605.
Chen, C.C., Wang, K.Y., and Shen, C.K. (2012). The mammalian de novo DNA
methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcy-
tosine dehydroxymethylases. J. Biol. Chem. 287, 33116–33121.
Chen, J., Guo, L., Zhang, L., Wu, H., Yang, J., Liu, H., Wang, X., Hu, X., Gu, T.,
Zhou, Z., et al. (2013a). Vitamin Cmodulates TET1 function during somatic cell
reprogramming. Nat. Genet. 45, 1504–1509.
Chen, Q., Chen, Y., Bian, C., Fujiki, R., and Yu, X. (2013b). TET2 promotes
histone O-GlcNAcylation during gene transcription. Nature 493, 561–564.
Cimmino, L., Abdel-Wahab, O., Levine, R.L., and Aifantis, I. (2011). TET family
proteins and their role in stem cell differentiation and transformation. Cell Stem
Cell 9, 193–204.
Clark, S.J., Harrison, J., Paul, C.L., and Frommer, M. (1994). High sensitivity
mapping of methylated cytosines. Nucleic Acids Res. 22, 2990–2997.
Clark, T.A., Lu, X., Luong, K., Dai, Q., Boitano, M., Turner, S.W., He, C., and
Korlach, J. (2013). Enhanced 5-methylcytosine detection in single-molecule,
real-time sequencing via Tet1 oxidation. BMC Biol. 11, 4.
Colquitt, B.M., Allen, W.E., Barnea, G., and Lomvardas, S. (2013). Alteration of
genic 5-hydroxymethylcytosine patterning in olfactory neurons correlates with
changes in gene expression and cell identity. Proc. Natl. Acad. Sci. USA 110,
14682–14687.
Conticello, S.G. (2008). The AID/APOBEC family of nucleic acid mutators.
Genome Biol. 9, 229.
Corta´zar, D., Kunz, C., Selfridge, J., Lettieri, T., Saito, Y., MacDougall, E., Wirz,
A., Schuermann, D., Jacobs, A.L., Siegrist, F., et al. (2011). Embryonic lethal
phenotype reveals a function of TDG in maintaining epigenetic stability. Nature
470, 419–423.
Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., Le Coz, M.,
Devarajan, K., Wessels, A., Soprano, D., et al. (2011). Thymine DNA glycosy-
lase is essential for active DNA demethylation by linked deamination-base
excision repair. Cell 146, 67–79.
Costa, Y., Ding, J., Theunissen, T.W., Faiola, F., Hore, T.A., Shliaha, P.V.,
Fidalgo, M., Saunders, A., Lawrence, M., Dietmann, S., et al. (2013).
NANOG-dependent function of TET1 and TET2 in establishment of pluripo-
tency. Nature 495, 370–374.
Dalton, S.R., and Bellacosa, A. (2012). DNA demethylation by TDG. Epigenom-
ics 4, 459–467.
Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M.,
Fantin, V.R., Jang, H.G., Jin, S., Keenan,M.C., et al. (2009). Cancer-associated
IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744.
Dawlaty, M.M., Ganz, K., Powell, B.E., Hu, Y.C., Markoulaki, S., Cheng, A.W.,
Gao, Q., Kim, J., Choi, S.W., Page, D.C., and Jaenisch, R. (2011). Tet1 is
dispensable for maintaining pluripotency and its loss is compatible with
embryonic and postnatal development. Cell Stem Cell 9, 166–175.
Dawlaty, M.M., Breiling, A., Le, T., Raddatz, G., Barrasa, M.I., Cheng, A.W.,
Gao, Q., Powell, B.E., Li, Z., Xu, M., et al. (2013). Combined deficiency of
Tet1 and Tet2 causes epigenetic abnormalities but is compatible with post-
natal development. Dev. Cell 24, 310–323.
Deaton, A.M., and Bird, A. (2011). CpG islands and the regulation of transcrip-
tion. Genes Dev. 25, 1010–1022.
Delhommeau, F., Dupont, S., Della Valle, V., James, C., Trannoy, S., Masse´, A.,
Kosmider, O., Le Couedic, J.P., Robert, F., Alberdi, A., et al. (2009). Mutation in
TET2 in myeloid cancers. N. Engl. J. Med. 360, 2289–2301.
Deplus, R., Delatte, B., Schwinn, M.K., Defrance, M., Me´ndez, J., Murphy, N.,
Dawson, M.A., Volkmar, M., Putmans, P., Calonne, E., et al. (2013). TET2 and
TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/
COMPASS. EMBO J. 32, 645–655.
Doege, C.A., Inoue, K., Yamashita, T., Rhee, D.B., Travis, S., Fujita, R., Guar-
nieri, P., Bhagat, G., Vanti, W.B., Shih, A., et al. (2012). Early-stage epigenetic
modification during somatic cell reprogramming by Parp1 and Tet2. Nature
488, 652–655.
Engel, N., Tront, J.S., Erinle, T., Nguyen, N., Latham, K.E., Sapienza, C., Hoff-
man, B., and Liebermann, D.A. (2009). Conserved DNA methylation in
Gadd45a(-/-) mice. Epigenetics 4, 98–99.
Esteller, M. (2007). Cancer epigenomics: DNA methylomes and histone-modi-
fication maps. Nat. Rev. Genet. 8, 286–298.
Fan, G., Beard, C., Chen, R.Z., Csankovszki, G., Sun, Y., Siniaia, M., Biniszkie-
wicz, D., Bates, B., Lee, P.P., Kuhn, R., et al. (2001). DNA hypomethylation
perturbs the function and survival of CNS neurons in postnatal animals.
J. Neurosci. 21, 788–797.
Fan, G., Martinowich, K., Chin, M.H., He, F., Fouse, S.D., Hutnick, L., Hattori,
D., Ge, W., Shen, Y., Wu, H., et al. (2005). DNA methylation controls the timing
of astrogliogenesis through regulation of JAK-STAT signaling. Development
132, 3345–3356.
Feng, J., Zhou, Y., Campbell, S.L., Le, T., Li, E., Sweatt, J.D., Silva, A.J., and
Fan, G. (2010a). Dnmt1 and Dnmt3a maintain DNA methylation and regulate
synaptic function in adult forebrain neurons. Nat. Neurosci. 13, 423–430.
Feng, S., Jacobsen, S.E., and Reik, W. (2010b). Epigenetic reprogramming in
plant and animal development. Science 330, 622–627.Ficz, G., Branco, M.R., Seisenberger, S., Santos, F., Krueger, F., Hore, T.A.,
Marques, C.J., Andrews, S., and Reik, W. (2011). Dynamic regulation of
5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature
473, 398–402.
Ficz, G., Hore, T.A., Santos, F., Lee, H.J., Dean, W., Arand, J., Krueger, F.,
Oxley, D., Paul, Y.L., Walter, J., et al. (2013). FGF signaling inhibition in
ESCs drives rapid genome-wide demethylation to the epigenetic ground state
of pluripotency. Cell Stem Cell 13, 351–359.
Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., Li, Y.,
Bhagwat, N., Vasanthakumar, A., Fernandez, H.F., et al. (2010). Leukemic
IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt
TET2 function, and impair hematopoietic differentiation. Cancer Cell 18,
553–567.
Fong, Y.W., Cattoglio, C., and Tjian, R. (2013). The intertwined roles of tran-
scription and repair proteins. Mol. Cell 52, 291–302.
Frauer, C., Hoffmann, T., Bultmann, S., Casa, V., Cardoso, M.C., Antes, I., and
Leonhardt, H. (2011). Recognition of 5-hydroxymethylcytosine by the Uhrf1
SRA domain. PLoS ONE 6, e21306.
Freudenberg, J.M., Ghosh, S., Lackford, B.L., Yellaboina, S., Zheng, X., Li, R.,
Cuddapah, S., Wade, P.A., Hu, G., and Jothi, R. (2012). Acute depletion of
Tet1-dependent 5-hydroxymethylcytosine levels impairs LIF/Stat3 signaling
and results in loss of embryonic stem cell identity. Nucleic Acids Res. 40,
3364–3377.
Gao, Y., Chen, J., Li, K., Wu, T., Huang, B., Liu, W., Kou, X., Zhang, Y., Huang,
H., Jiang, Y., et al. (2013). Replacement of Oct4 by Tet1 during iPSC induction
reveals an important role of DNA methylation and hydroxymethylation in
reprogramming. Cell Stem Cell 12, 453–469.
Globisch, D., Mu¨nzel, M., Mu¨ller, M., Michalakis, S., Wagner, M., Koch, S.,
Bru¨ckl, T., Biel, M., and Carell, T. (2010). Tissue distribution of 5-hydroxyme-
thylcytosine and search for active demethylation intermediates. PLoS ONE
5, e15367.
Goll, M.G., and Bestor, T.H. (2005). Eukaryotic cytosine methyltransferases.
Annu. Rev. Biochem. 74, 481–514.
Gu, T.P., Guo, F., Yang, H.,Wu, H.P., Xu, G.F., Liu, W., Xie, Z.G., Shi, L., He, X.,
Jin, S.G., et al. (2011). The role of Tet3 DNA dioxygenase in epigenetic reprog-
ramming by oocytes. Nature 477, 606–610.
Guo, J.U., Su, Y., Zhong, C., Ming, G.L., and Song, H. (2011). Hydroxylation of
5-methylcytosine by TET1 promotes active DNA demethylation in the adult
brain. Cell 145, 423–434.
Habibi, E., Brinkman, A.B., Arand, J., Kroeze, L.I., Kerstens, H.H., Matarese,
F., Lepikhov, K., Gut, M., Brun-Heath, I., Hubner, N.C., et al. (2013). Whole-
genome bisulfite sequencing of two distinct interconvertible DNA methylomes
of mouse embryonic stem cells. Cell Stem Cell 13, 360–369.
Hackett, J.A., Sengupta, R., Zylicz, J.J., Murakami, K., Lee, C., Down, T.A.,
and Surani, M.A. (2013). Germline DNA demethylation dynamics and imprint
erasure through 5-hydroxymethylcytosine. Science 339, 448–452.
Hahn, M.A., Qiu, R., Wu, X., Li, A.X., Zhang, H., Wang, J., Jui, J., Jin, S.G.,
Jiang, Y., Pfeifer, G.P., and Lu, Q. (2013). Dynamics of 5-hydroxymethylcyto-
sine and chromatin marks in Mammalian neurogenesis. Cell Rep. 3, 291–300.
Hajkova, P., Erhardt, S., Lane, N., Haaf, T., El-Maarri, O., Reik, W., Walter, J.,
and Surani, M.A. (2002). Epigenetic reprogramming in mouse primordial germ
cells. Mech. Dev. 117, 15–23.
Hajkova, P., Jeffries, S.J., Lee, C., Miller, N., Jackson, S.P., and Surani, M.A.
(2010). Genome-wide reprogramming in the mouse germ line entails the
base excision repair pathway. Science 329, 78–82.
Hanna, J.H., Saha, K., and Jaenisch, R. (2010). Pluripotency and cellular
reprogramming: facts, hypotheses, unresolved issues. Cell 143, 508–525.
Hashimoto, H., Vertino, P.M., and Cheng, X. (2010). Molecular coupling of DNA
methylation and histone methylation. Epigenomics 2, 657–669.
Hashimoto, H., Liu, Y., Upadhyay, A.K., Chang, Y., Howerton, S.B., Vertino,
P.M., Zhang, X., and Cheng, X. (2012). Recognition and potential mechanisms
for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res.
40, 4841–4849.Cell 156, January 16, 2014 ª2014 Elsevier Inc. 63
Hashimoto, H., Pais, J.E., Zhang, X., Saleh, L., Fu, Z.-Q., Dai, N., Correˆa, I.R.,
Zheng, Y., and Cheng, X. (2013). Structure of a Naegleria Tet-like dioxygenase
in complex with 5-methylcytosine DNA. Nature. Published online December
25, 2013. http://dx.doi.org/10.1038/nature12905.
He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li,
L., et al. (2011). Tet-mediated formation of 5-carboxylcytosine and its excision
by TDG in mammalian DNA. Science 333, 1303–1307.
Hermann, A., Goyal, R., and Jeltsch, A. (2004). The Dnmt1 DNA-(cytosine-C5)-
methyltransferasemethylates DNA processively with high preference for hemi-
methylated target sites. J. Biol. Chem. 279, 48350–48359.
Holliday, R., and Pugh, J.E. (1975). DNA modification mechanisms and gene
activity during development. Science 187, 226–232.
Hsu, C.H., Peng, K.L., Kang, M.L., Chen, Y.R., Yang, Y.C., Tsai, C.H., Chu,
C.S., Jeng, Y.M., Chen, Y.T., Lin, F.M., et al. (2012). TET1 suppresses cancer
invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2,
568–579.
Hu, L., Li, Z., Cheng, J., Rao, Q., Gong,W., Liu, M., Shi, Y.G., Zhu, J., Wang, P.,
and Xu, Y. (2013). Crystal Structure of TET2-DNA Complex: Insight into TET-
Mediated 5mC Oxidation. Cell 155, 1545–1555.
Huang, Y., Pastor, W.A., Shen, Y., Tahiliani, M., Liu, D.R., and Rao, A. (2010).
The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS ONE
5, e8888.
Huang, Y., Pastor, W.A., Zepeda-Martı´nez, J.A., and Rao, A. (2012). The anti-
CMS technique for genome-wide mapping of 5-hydroxymethylcytosine. Nat.
Protoc. 7, 1897–1908.
Inoue, A., and Zhang, Y. (2011). Replication-dependent loss of 5-hydroxyme-
thylcytosine in mouse preimplantation embryos. Science 334, 194.
Inoue, A., Shen, L., Dai, Q., He, C., and Zhang, Y. (2011). Generation and repli-
cation-dependent dilution of 5fC and 5caC during mouse preimplantation
development. Cell Res. 21, 1670–1676.
Iqbal, K., Jin, S.G., Pfeifer, G.P., and Szabo´, P.E. (2011). Reprogramming of the
paternal genome upon fertilization involves genome-wide oxidation of 5-meth-
ylcytosine. Proc. Natl. Acad. Sci. USA 108, 3642–3647.
Ito, S., D’Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C., and Zhang, Y.
(2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal
and inner cell mass specification. Nature 466, 1129–1133.
Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C., and
Zhang, Y. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcyto-
sine and 5-carboxylcytosine. Science 333, 1300–1303.
Iurlaro, M., Ficz, G., Oxley, D., Raiber, E.A., Bachman, M., Booth, M.J.,
Andrews, S., Balasubramanian, S., and Reik, W. (2013). A screen for hydrox-
ymethylcytosine and formylcytosine binding proteins suggests functions in
transcription and chromatin regulation. Genome Biol. 14, R119.
Iyer, L.M., Tahiliani, M., Rao, A., and Aravind, L. (2009). Prediction of novel
families of enzymes involved in oxidative and other complex modifications of
bases in nucleic acids. Cell Cycle 8, 1698–1710.
Jaenisch, R., and Bird, A. (2003). Epigenetic regulation of gene expression:
how the genome integrates intrinsic and environmental signals. Nat. Genet.
Suppl. 33, 245–254.
Ji, H., Ehrlich, L.I., Seita, J., Murakami, P., Doi, A., Lindau, P., Lee, H., Aryee,
M.J., Irizarry, R.A., Kim, K., et al. (2010). Comprehensive methylome map of
lineage commitment from haematopoietic progenitors. Nature 467, 338–342.
Jiang, L., Zhang, J., Wang, J.J., Wang, L., Zhang, L., Li, G., Yang, X., Ma, X.,
Sun, X., Cai, J., et al. (2013). Sperm, but not oocyte, DNA methylome is
inherited by zebrafish early embryos. Cell 153, 773–784.
Jin, S.G., Guo, C., and Pfeifer, G.P. (2008). GADD45A does not promote DNA
demethylation. PLoS Genet. 4, e1000013.
Kaas, G.A., Zhong, C., Eason, D.E., Ross, D.L., Vachhani, R.V., Ming, G.L.,
King, J.R., Song, H., and Sweatt, J.D. (2013). TET1 controls CNS 5-methylcy-
tosine hydroxylation, active DNA demethylation, gene transcription, and
memory formation. Neuron 79, 1086–1093.64 Cell 156, January 16, 2014 ª2014 Elsevier Inc.Kaelin, W.G., Jr., andMcKnight, S.L. (2013). Influence of metabolism on epige-
netics and disease. Cell 153, 56–69.
Kagiwada, S., Kurimoto, K., Hirota, T., Yamaji, M., and Saitou,M. (2013). Repli-
cation-coupled passive DNA demethylation for the erasure of genome imprints
in mice. EMBO J. 32, 340–353.
Kellinger, M.W., Song, C.X., Chong, J., Lu, X.Y., He, C., and Wang, D. (2012).
5-formylcytosine and 5-carboxylcytosine reduce the rate and substrate spec-
ificity of RNA polymerase II transcription. Nat. Struct. Mol. Biol. 19, 831–833.
Kemmerich, K., Dingler, F.A., Rada, C., and Neuberger, M.S. (2012). Germline
ablation of SMUG1 DNA glycosylase causes loss of 5-hydroxymethyluracil-
and UNG-backup uracil-excision activities and increases cancer predisposi-
tion of Ung-/-Msh2-/- mice. Nucleic Acids Res. 40, 6016–6025.
Klose, R.J., Kallin, E.M., and Zhang, Y. (2006). JmjC-domain-containing
proteins and histone demethylation. Nat. Rev. Genet. 7, 715–727.
Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala,
H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, R., et al. (2010). Impaired
hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
Nature 468, 839–843.
Ko, M., Bandukwala, H.S., An, J., Lamperti, E.D., Thompson, E.C., Hastie, R.,
Tsangaratou, A., Rajewsky, K., Koralov, S.B., and Rao, A. (2011). Ten-Eleven-
Translocation 2 (TET2) negatively regulates homeostasis and differentiation of
hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 108, 14566–
14571.
Ko, M., An, J., Bandukwala, H.S., Chavez, L., Aijo¨, T., Pastor, W.A., Segal,
M.F., Li, H., Koh, K.P., La¨hdesma¨ki, H., et al. (2013). Modulation of TET2
expression and 5-methylcytosine oxidation by the CXXC domain protein
IDAX. Nature 497, 122–126.
Kobayashi, H., Sakurai, T., Imai, M., Takahashi, N., Fukuda, A., Yayoi, O., Sato,
S., Nakabayashi, K., Hata, K., Sotomaru, Y., et al. (2012). Contribution of intra-
genic DNA methylation in mouse gametic DNA methylomes to establish
oocyte-specific heritable marks. PLoS Genet. 8, e1002440.
Koh, K.P., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A.,
Tahiliani, M., Sommer, C.A., Mostoslavsky, G., et al. (2011). Tet1 and Tet2
regulate 5-hydroxymethylcytosine production and cell lineage specification
in mouse embryonic stem cells. Cell Stem Cell 8, 200–213.
Kohli, R.M., and Zhang, Y. (2013). TET enzymes, TDG and the dynamics of
DNA demethylation. Nature 502, 472–479.
Kriaucionis, S., and Heintz, N. (2009). The nuclear DNA base 5-hydroxymethyl-
cytosine is present in Purkinje neurons and the brain. Science 324, 929–930.
Kumar, R., DiMenna, L., Schrode, N., Liu, T.C., Franck, P., Mun˜oz-Descalzo,
S., Hadjantonakis, A.K., Zarrin, A.A., Chaudhuri, J., Elemento, O., and Evans,
T. (2013). AID stabilizes stem-cell phenotype by removing epigenetic memory
of pluripotency genes. Nature 500, 89–92.
Lane, N., Dean,W., Erhardt, S., Hajkova, P., Surani, A., Walter, J., and Reik, W.
(2003). Resistance of IAPs to methylation reprogramming may provide a
mechanism for epigenetic inheritance in the mouse. Genesis 35, 88–93.
Langemeijer, S.M., Kuiper, R.P., Berends, M., Knops, R., Aslanyan, M.G.,
Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A.G.,
Raymakers, R.A., et al. (2009). Acquired mutations in TET2 are common in
myelodysplastic syndromes. Nat. Genet. 41, 838–842.
LaPlant, Q., Vialou, V., Covington, H.E., 3rd, Dumitriu, D., Feng, J., Warren,
B.L., Maze, I., Dietz, D.M., Watts, E.L., In˜iguez, S.D., et al. (2010). Dnmt3a
regulates emotional behavior and spine plasticity in the nucleus accumbens.
Nat. Neurosci. 13, 1137–1143.
Law, J.A., and Jacobsen, S.E. (2010). Establishing, maintaining and modifying
DNAmethylation patterns in plants and animals. Nat. Rev. Genet. 11, 204–220.
Leitch, H.G., McEwen, K.R., Turp, A., Encheva, V., Carroll, T., Grabole, N.,
Mansfield, W., Nashun, B., Knezovich, J.G., Smith, A., et al. (2013). Naive
pluripotency is associated with global DNA hypomethylation. Nat. Struct.
Mol. Biol. 20, 311–316.
Li, X., Ito, M., Zhou, F., Youngson, N., Zuo, X., Leder, P., and Ferguson-Smith,
A.C. (2008). A maternal-zygotic effect gene, Zfp57, maintains both maternal
and paternal imprints. Dev. Cell 15, 547–557.
Li, Z., Cai, X., Cai, C.L., Wang, J., Zhang, W., Petersen, B.E., Yang, F.C., and
Xu, M. (2011). Deletion of Tet2 in mice leads to dysregulated hematopoietic
stem cells and subsequent development of myeloid malignancies. Blood
118, 4509–4518.
Li, W.W., Gong, L., and Bayley, H. (2013). Single-molecule detection of
5-hydroxymethylcytosine in DNA through chemical modification and nano-
pore analysis. Angew. Chem. Int. Ed. Engl. 52, 4350–4355.
Lian, C.G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu,
Y., Zhan, Q., et al. (2012). Loss of 5-hydroxymethylcytosine is an epigenetic
hallmark of melanoma. Cell 150, 1135–1146.
Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini,
J., Nery, J.R., Lee, L., Ye, Z., Ngo, Q.M., et al. (2009). Human DNAmethylomes
at base resolution show widespread epigenomic differences. Nature 462,
315–322.
Lister, R., Mukamel, E.A., Nery, J.R., Urich, M., Puddifoot, C.A., Johnson, N.D.,
Lucero, J., Huang, Y., Dwork, A.J., Schultz, M.D., et al. (2013). Global epige-
nomic reconfiguration during mammalian brain development. Science 341,
1237905.
Liu, Y., Toh, H., Sasaki, H., Zhang, X., and Cheng, X. (2012). An atomic model
of Zfp57 recognition of CpG methylation within a specific DNA sequence.
Genes Dev. 26, 2374–2379.
Liutkeviciute, Z., Lukinavicius, G., Masevicius, V., Daujotyte, D., and Klima-
sauskas, S. (2009). Cytosine-5-methyltransferases add aldehydes to DNA.
Nat. Chem. Biol. 5, 400–402.
Loenarz, C., and Schofield, C.J. (2011). Physiological and biochemical aspects
of hydroxylations and demethylations catalyzed by human 2-oxoglutarate
oxygenases. Trends Biochem. Sci. 36, 7–18.
Long, H.K., Blackledge, N.P., and Klose, R.J. (2013). ZF-CxxC domain-
containing proteins, CpG islands and the chromatin connection. Biochem.
Soc. Trans. 41, 727–740.
Lorsbach, R.B., Moore, J., Mathew, S., Raimondi, S.C., Mukatira, S.T., and
Downing, J.R. (2003). TET1, a member of a novel protein family, is fused to
MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia
17, 637–641.
Lu, X., Song, C.X., Szulwach, K., Wang, Z., Weidenbacher, P., Jin, P., and He,
C. (2013). Chemical modification-assisted bisulfite sequencing (CAB-Seq) for
5-carboxylcytosine detection in DNA. J. Am. Chem. Soc. 135, 9315–9317.
Ma, D.K., Jang, M.H., Guo, J.U., Kitabatake, Y., Chang, M.L., Pow-Anpongkul,
N., Flavell, R.A., Lu, B., Ming, G.L., and Song, H. (2009). Neuronal activity-
induced Gadd45b promotes epigenetic DNA demethylation and adult neuro-
genesis. Science 323, 1074–1077.
Maeder, M.L., Angstman, J.F., Richardson, M.E., Linder, S.J., Cascio, V.M.,
Tsai, S.Q., Ho, Q.H., Sander, J.D., Reyon, D., Bernstein, B.E., et al. (2013).
Targeted DNA demethylation and activation of endogenous genes using
programmable TALE-TET1 fusion proteins. Nat. Biotechnol. 31, 1137–1142.
Maiti, A., and Drohat, A.C. (2011). Thymine DNA glycosylase can rapidly excise
5-formylcytosine and 5-carboxylcytosine: potential implications for active
demethylation of CpG sites. J. Biol. Chem. 286, 35334–35338.
Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H.,
Nichols, J., Kranz, A., Stewart, A.F., Smith, A., and Stunnenberg, H.G.
(2012). The transcriptional and epigenomic foundations of ground state plurip-
otency. Cell 149, 590–604.
Matarese, F., Carrillo-de Santa Pau, E., and Stunnenberg, H.G. (2011).
5-Hydroxymethylcytosine: a new kid on the epigenetic block? Mol. Syst.
Biol. 7, 562.
Mayer, W., Niveleau, A., Walter, J., Fundele, R., and Haaf, T. (2000). Demethy-
lation of the zygotic paternal genome. Nature 403, 501–502.
Melle´n, M., Ayata, P., Dewell, S., Kriaucionis, S., and Heintz, N. (2012). MeCP2
binds to 5hmC enriched within active genes and accessible chromatin in the
nervous system. Cell 151, 1417–1430.
Messerschmidt, D.M., de Vries,W., Ito, M., Solter, D., Ferguson-Smith, A., and
Knowles, B.B. (2012). Trim28 is required for epigenetic stability during mouse
oocyte to embryo transition. Science 335, 1499–1502.Me´tivier, R., Gallais, R., Tiffoche, C., Le Pe´ron, C., Jurkowska, R.Z.,
Carmouche, R.P., Ibberson, D., Barath, P., Demay, F., Reid, G., et al. (2008).
Cyclical DNA methylation of a transcriptionally active promoter. Nature 452,
45–50.
Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G.,
Alvarez, P., Brockman, W., Kim, T.K., Koche, R.P., et al. (2007). Genome-wide
maps of chromatin state in pluripotent and lineage-committed cells. Nature
448, 553–560.
Millar, C.B., Guy, J., Sansom, O.J., Selfridge, J., MacDougall, E., Hendrich, B.,
Keightley, P.D., Bishop, S.M., Clarke, A.R., and Bird, A. (2002). Enhanced CpG
mutability and tumorigenesis in MBD4-deficient mice. Science 297, 403–405.
Minor, E.A., Court, B.L., Young, J.I., and Wang, G. (2013). Ascorbate induces
ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated genera-
tion of 5-hydroxymethylcytosine. J. Biol. Chem. 288, 13669–13674.
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D.,
Lobry, C., Figueroa, M.E., Vasanthakumar, A., Patel, J., Zhao, X., et al.
(2011). Tet2 loss leads to increased hematopoietic stem cell self-renewal
and myeloid transformation. Cancer Cell 20, 11–24.
Morgan, H.D., Dean, W., Coker, H.A., Reik, W., and Petersen-Mahrt, S.K.
(2004). Activation-induced cytidine deaminase deaminates 5-methylcytosine
in DNA and is expressed in pluripotent tissues: implications for epigenetic
reprogramming. J. Biol. Chem. 279, 52353–52360.
Mu¨nzel, M., Globisch, D., Bru¨ckl, T., Wagner, M.,Welzmiller, V., Michalakis, S.,
Mu¨ller, M., Biel, M., and Carell, T. (2010). Quantification of the sixth DNA base
hydroxymethylcytosine in the brain. Angew. Chem. Int. Ed. Engl. 49, 5375–
5377.
Nabel, C.S., Jia, H., Ye, Y., Shen, L., Goldschmidt, H.L., Stivers, J.T., Zhang,
Y., and Kohli, R.M. (2012). AID/APOBEC deaminases disfavor modified cyto-
sines implicated in DNA demethylation. Nat. Chem. Biol. 8, 751–758.
Nakamura, T., Arai, Y., Umehara, H., Masuhara, M., Kimura, T., Taniguchi, H.,
Sekimoto, T., Ikawa, M., Yoneda, Y., Okabe, M., et al. (2007). PGC7/Stella
protects against DNA demethylation in early embryogenesis. Nat. Cell Biol.
9, 64–71.
Nakamura, T., Liu, Y.J., Nakashima, H., Umehara, H., Inoue, K., Matoba, S.,
Tachibana, M., Ogura, A., Shinkai, Y., and Nakano, T. (2012). PGC7 binds
histone H3K9me2 to protect against conversion of 5mC to 5hmC in early
embryos. Nature 486, 415–419.
Nguyen, S., Meletis, K., Fu, D., Jhaveri, S., and Jaenisch, R. (2007). Ablation of
de novo DNAmethyltransferase Dnmt3a in the nervous system leads to neuro-
muscular defects and shortened lifespan. Dev. Dyn. 236, 1663–1676.
Okada, Y., Yamagata, K., Hong, K.,Wakayama, T., and Zhang, Y. (2010). A role
for the elongator complex in zygotic paternal genome demethylation. Nature
463, 554–558.
Okano, M., Xie, S., and Li, E. (1998). Cloning and characterization of a family of
novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19,
219–220.
Okano, M., Bell, D.W., Haber, D.A., and Li, E. (1999). DNA methyltransferases
Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian
development. Cell 99, 247–257.
Ono, R., Taki, T., Taketani, T., Taniwaki, M., Kobayashi, H., and Hayashi, Y.
(2002). LCX, leukemia-associated protein with a CXXC domain, is fused
to MLL in acute myeloid leukemia with trilineage dysplasia having
t(10;11)(q22;q23). Cancer Res. 62, 4075–4080.
Ooi, S.K., and Bestor, T.H. (2008). The colorful history of active DNA demethy-
lation. Cell 133, 1145–1148.
Ooi, S.K., Qiu, C., Bernstein, E., Li, K., Jia, D., Yang, Z., Erdjument-Bromage,
H., Tempst, P., Lin, S.P., Allis, C.D., et al. (2007). DNMT3L connects unmethy-
lated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448,
714–717.
Oswald, J., Engemann, S., Lane, N., Mayer, W., Olek, A., Fundele, R., Dean,
W., Reik, W., and Walter, J. (2000). Active demethylation of the paternal
genome in the mouse zygote. Curr. Biol. 10, 475–478.Cell 156, January 16, 2014 ª2014 Elsevier Inc. 65
Otani, J., Arita, K., Kato, T., Kinoshita, M., Kimura, H., Suetake, I., Tajima, S.,
Ariyoshi, M., and Shirakawa, M. (2013a). Structural basis of the versatile DNA
recognition ability of the methyl-CpG binding domain of methyl-CpG binding
domain protein 4. J. Biol. Chem. 288, 6351–6362.
Otani, J., Kimura, H., Sharif, J., Endo, T.A., Mishima, Y., Kawakami, T., Koseki,
H., Shirakawa, M., Suetake, I., and Tajima, S. (2013b). Cell cycle-dependent
turnover of 5-hydroxymethyl Cytosine in mouse embryonic stem cells. PLoS
ONE 8, e82961.
Pastor, W.A., Pape, U.J., Huang, Y., Henderson, H.R., Lister, R., Ko, M.,
McLoughlin, E.M., Brudno, Y., Mahapatra, S., Kapranov, P., et al. (2011).
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells.
Nature 473, 394–397.
Pastor, W.A., Aravind, L., and Rao, A. (2013). TETonic shift: biological roles of
TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol.
14, 341–356.
Payer, B., Saitou, M., Barton, S.C., Thresher, R., Dixon, J.P.C., Zahn, D.,
Colledge, W.H., Carlton, M.B.L., Nakano, T., and Surani, M.A. (2003). Stella
is a maternal effect gene required for normal early development in mice.
Curr. Biol. 13, 2110–2117.
Pfaffeneder, T., Hackner, B., Truss, M., Mu¨nzel, M., Mu¨ller, M., Deiml, C.A.,
Hagemeier, C., and Carell, T. (2011). The discovery of 5-formylcytosine in
embryonic stem cell DNA. Angew. Chem. Int. Ed. Engl. 50, 7008–7012.
Piccolo, F.M., Bagci, H., Brown, K.E., Landeira, D., Soza-Ried, J., Feytout, A.,
Mooijman, D., Hajkova, P., Leitch, H.G., Tada, T., et al. (2013). Different roles
for Tet1 and Tet2 proteins in reprogramming-mediated erasure of imprints
induced by EGC fusion. Mol. Cell 49, 1023–1033.
Popp, C., Dean, W., Feng, S., Cokus, S.J., Andrews, S., Pellegrini, M., Jacob-
sen, S.E., and Reik, W. (2010). Genome-wide erasure of DNA methylation in
mouse primordial germ cells is affected by AID deficiency. Nature 463,
1101–1105.
Potok, M.E., Nix, D.A., Parnell, T.J., and Cairns, B.R. (2013). Reprogramming
the maternal zebrafish genome after fertilization to match the paternal methyl-
ation pattern. Cell 153, 759–772.
Quenneville, S., Verde, G., Corsinotti, A., Kapopoulou, A., Jakobsson, J.,
Offner, S., Baglivo, I., Pedone, P.V., Grimaldi, G., Riccio, A., and Trono, D.
(2011). In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanu-
cleotide to affect chromatin and DNAmethylation of imprinting control regions.
Mol. Cell 44, 361–372.
Quivoron, C., Couronne´, L., Della Valle, V., Lopez, C.K., Plo, I., Wagner-Ballon,
O., DoCruzeiro, M., Delhommeau, F., Arnulf, B., Stern, M.H., et al. (2011). TET2
inactivation results in pleiotropic hematopoietic abnormalities in mouse and is
a recurrent event during human lymphomagenesis. Cancer Cell 20, 25–38.
Rai, K., Huggins, I.J., James, S.R., Karpf, A.R., Jones, D.A., and Cairns, B.R.
(2008). DNA demethylation in zebrafish involves the coupling of a deaminase,
a glycosylase, and gadd45. Cell 135, 1201–1212.
Raiber, E.A., Beraldi, D., Ficz, G., Burgess, H.E., Branco, M.R., Murat, P.,
Oxley, D., Booth, M.J., Reik, W., and Balasubramanian, S. (2012). Genome-
wide distribution of 5-formylcytosine in embryonic stem cells is associated
with transcription and depends on thymine DNA glycosylase. Genome Biol.
13, R69.
Riggs, A.D. (1975). X inactivation, differentiation, and DNA methylation. Cyto-
genet. Cell Genet. 14, 9–25.
Robertson, A.B., Dahl, J.A., Va˚gbø, C.B., Tripathi, P., Krokan, H.E., and Klung-
land, A. (2011). A novel method for the efficient and selective identification of
5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 39, e55.
Rudenko, A., Dawlaty, M.M., Seo, J., Cheng, A.W., Meng, J., Le, T., Faull, K.F.,
Jaenisch, R., and Tsai, L.H. (2013). Tet1 is critical for neuronal activity-regu-
lated gene expression and memory extinction. Neuron 79, 1109–1122.
Saitou, M., Kagiwada, S., and Kurimoto, K. (2012). Epigenetic reprogramming
in mouse pre-implantation development and primordial germ cells. Develop-
ment 139, 15–31.
Sasaki, H., and Matsui, Y. (2008). Epigenetic events in mammalian germ-cell
development: reprogramming and beyond. Nat. Rev. Genet. 9, 129–140.66 Cell 156, January 16, 2014 ª2014 Elsevier Inc.Schiesser, S., Hackner, B., Pfaffeneder, T., Mu¨ller, M., Hagemeier, C., Truss,
M., and Carell, T. (2012). Mechanism and stem-cell activity of 5-carboxycyto-
sine decarboxylation determined by isotope tracing. Angew. Chem. Int. Ed.
Engl. 51, 6516–6520.
Schmitz, K.M., Schmitt, N., Hoffmann-Rohrer, U., Scha¨fer, A., Grummt, I., and
Mayer, C. (2009). TAF12 recruits Gadd45a and the nucleotide excision repair
complex to the promoter of rRNA genes leading to active DNA demethylation.
Mol. Cell 33, 344–353.
Seisenberger, S., Andrews, S., Krueger, F., Arand, J., Walter, J., Santos, F.,
Popp, C., Thienpont, B., Dean, W., and Reik, W. (2012). The dynamics of
genome-wide DNA methylation reprogramming in mouse primordial germ
cells. Mol. Cell 48, 849–862.
Seisenberger, S., Peat, J.R., and Reik, W. (2013). Conceptual links between
DNA methylation reprogramming in the early embryo and primordial germ
cells. Curr. Opin. Cell Biol. 25, 281–288.
Sharif, J., Muto, M., Takebayashi, S., Suetake, I., Iwamatsu, A., Endo, T.A.,
Shinga, J., Mizutani-Koseki, Y., Toyoda, T., Okamura, K., et al. (2007). The
SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to
methylated DNA. Nature 450, 908–912.
Shearstone, J.R., Pop, R., Bock, C., Boyle, P., Meissner, A., and Socolovsky,
M. (2011). Global DNA demethylation during mouse erythropoiesis in vivo.
Science 334, 799–802.
Shen, Y., Yue, F., McCleary, D.F., Ye, Z., Edsall, L., Kuan, S., Wagner, U.,
Dixon, J., Lee, L., Lobanenkov, V.V., and Ren, B. (2012). A map of the cis-
regulatory sequences in the mouse genome. Nature 488, 116–120.
Shen, L., Wu, H., Diep, D., Yamaguchi, S., D’Alessio, A.C., Fung, H.L., Zhang,
K., and Zhang, Y. (2013). Genome-wide analysis reveals TET- and TDG-
dependent 5-methylcytosine oxidation dynamics. Cell 153, 692–706.
Shirane, K., Toh, H., Kobayashi, H., Miura, F., Chiba, H., Ito, T., Kono, T., and
Sasaki, H. (2013). Mouse oocyte methylomes at base resolution reveal
genome-wide accumulation of non-CpG methylation and role of DNA methyl-
transferases. PLoS Genet. 9, e1003439.
Smallwood, S.A., Tomizawa, S., Krueger, F., Ruf, N., Carli, N., Segonds-
Pichon, A., Sato, S., Hata, K., Andrews, S.R., and Kelsey, G. (2011). Dynamic
CpG island methylation landscape in oocytes and preimplantation embryos.
Nat. Genet. 43, 811–814.
Smiley, J.A., Kundracik, M., Landfried, D.A., Barnes, V.R., Sr., and Axhemi,
A.A. (2005). Genes of the thymidine salvage pathway: thymine-7-hydroxylase
from a Rhodotorula glutinis cDNA library and iso-orotate decarboxylase from
Neurospora crassa. Biochim. Biophys. Acta 1723, 256–264.
Smith, Z.D., and Meissner, A. (2013). DNA methylation: roles in mammalian
development. Nat. Rev. Genet. 14, 204–220.
Smith, Z.D., Chan, M.M., Mikkelsen, T.S., Gu, H., Gnirke, A., Regev, A., and
Meissner, A. (2012). A unique regulatory phase of DNAmethylation in the early
mammalian embryo. Nature 484, 339–344.
Song, C.X., and He, C. (2013). Potential functional roles of DNA demethylation
intermediates. Trends Biochem. Sci. 38, 480–484.
Song, C.X., Szulwach, K.E., Fu, Y., Dai, Q., Yi, C., Li, X., Li, Y., Chen, C.H.,
Zhang, W., Jian, X., et al. (2011). Selective chemical labeling reveals the
genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29,
68–72.
Song, C.X., Clark, T.A., Lu, X.Y., Kislyuk, A., Dai, Q., Turner, S.W., He, C., and
Korlach, J. (2012a). Sensitive and specific single-molecule sequencing of
5-hydroxymethylcytosine. Nat. Methods 9, 75–77.
Song, C.X., Yi, C., and He, C. (2012b). Mapping recently identified nucleotide
variants in the genome and transcriptome. Nat. Biotechnol. 30, 1107–1116.
Song, C.-X., Szulwach, K.E., Dai, Q., Fu, Y., Mao, S.-Q., Lin, L., Street, C., Li,
Y., Poidevin, M., Wu, H., et al. (2013a). Genome-wide profiling of 5-formylcy-
tosine reveals its roles in epigenetic priming. Cell 153, 678–691.
Song, S.J., Ito, K., Ala, U., Kats, L., Webster, K., Sun, S.M., Jongen-Lavrencic,
M., Manova-Todorova, K., Teruya-Feldstein, J., Avigan, D.E., et al. (2013b).
The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to
promote hematopoietic stem cell self-renewal and transformation. Cell Stem
Cell 13, 87–101.
Song, S.J., Poliseno, L., Song, M.S., Ala, U., Webster, K., Ng, C., Beringer, G.,
Brikbak, N.J., Yuan, X., Cantley, L.C., et al. (2013c). MicroRNA-antagonism
regulates breast cancer stemness and metastasis via TET-family-dependent
chromatin remodeling. Cell 154, 311–324.
Spruijt, C.G., Gnerlich, F., Smits, A.H., Pfaffeneder, T., Jansen, P.W.T.C.,
Bauer, C., Mu¨nzel, M., Wagner, M., Mu¨ller, M., Khan, F., et al. (2013). Dynamic
readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152,
1146–1159.
Stadler, M.B., Murr, R., Burger, L., Ivanek, R., Lienert, F., Scho¨ler, A., van
Nimwegen, E., Wirbelauer, C., Oakeley, E.J., Gaidatzis, D., et al. (2011).
DNA-binding factors shape the mouse methylome at distal regulatory regions.
Nature 480, 490–495.
Stivers, J.T., and Jiang, Y.L. (2003). A mechanistic perspective on the chemis-
try of DNA repair glycosylases. Chem. Rev. 103, 2729–2759.
Stroud, H., Feng, S., Morey Kinney, S., Pradhan, S., and Jacobsen, S.E. (2011).
5-Hydroxymethylcytosine is associated with enhancers and gene bodies in
human embryonic stem cells. Genome Biol. 12, R54.
Szulwach, K.E., Li, X., Li, Y., Song, C.X., Han, J.W., Kim, S., Namburi, S.,
Hermetz, K., Kim, J.J., Rudd,M.K., et al. (2011a). Integrating 5-hydroxymethyl-
cytosine into the epigenomic landscape of human embryonic stem cells. PLoS
Genet. 7, e1002154.
Szulwach, K.E., Li, X., Li, Y., Song, C.X., Wu, H., Dai, Q., Irier, H., Upadhyay,
A.K., Gearing, M., Levey, A.I., et al. (2011b). 5-hmC-mediated epigenetic
dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 14,
1607–1616.
Szwagierczak, A., Bultmann, S., Schmidt, C.S., Spada, F., and Leonhardt, H.
(2010). Sensitive enzymatic quantification of 5-hydroxymethylcytosine in
genomic DNA. Nucleic Acids Res. 38, e181.
Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y.,
Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L., and Rao, A. (2009). Conversion
of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL
partner TET1. Science 324, 930–935.
Tang, F., Barbacioru, C., Nordman, E., Bao, S., Lee, C., Wang, X., Tuch, B.B.,
Heard, E., Lao, K., and Surani, M.A. (2011). Deterministic and stochastic allele
specific gene expression in single mouse blastomeres. PLoS ONE 6, e21208.
Thomson, J.P., Hunter, J.M., Nestor, C.E., Dunican, D.S., Terranova, R.,
Moggs, J.G., and Meehan, R.R. (2013). Comparative analysis of affinity-based
5-hydroxymethylation enrichment techniques. Nucleic Acids Res. 41, e206.
Valinluck, V., Tsai, H.H., Rogstad, D.K., Burdzy, A., Bird, A., and Sowers, L.C.
(2004). Oxidative damage to methyl-CpG sequences inhibits the binding of the
methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).
Nucleic Acids Res. 32, 4100–4108.
Vella, P., Scelfo, A., Jammula, S., Chiacchiera, F., Williams, K., Cuomo, A.,
Roberto, A., Christensen, J., Bonaldi, T., Helin, K., and Pasini, D. (2013). Tet
proteins connect the O-linked N-acetylglucosamine transferase Ogt to chro-
matin in embryonic stem cells. Mol. Cell 49, 645–656.
Vincent, J.J., Huang, Y., Chen, P.Y., Feng, S., Calvopin˜a, J.H., Nee, K., Lee,
S.A., Le, T., Yoon, A.J., Faull, K., et al. (2013). Stage-specific roles for tet1
and tet2 in DNA demethylation in primordial germ cells. Cell Stem Cell 12,
470–478.
Wanunu, M., Cohen-Karni, D., Johnson, R.R., Fields, L., Benner, J., Peterman,
N., Zheng, Y., Klein, M.L., and Drndic, M. (2011). Discrimination of methylcyto-
sine from hydroxymethylcytosine in DNA molecules. J. Am. Chem. Soc. 133,
486–492.
Ward, P.S., Patel, J., Wise, D.R., Abdel-Wahab, O., Bennett, B.D., Coller, H.A.,
Cross, J.R., Fantin, V.R., Hedvat, C.V., Perl, A.E., et al. (2010). The common
feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic
enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer
Cell 17, 225–234.Whyte, W.A., Bilodeau, S., Orlando, D.A., Hoke, H.A., Frampton, G.M., Foster,
C.T., Cowley, S.M., and Young, R.A. (2012). Enhancer decommissioning by
LSD1 during embryonic stem cell differentiation. Nature 482, 221–225.
Williams, K., Christensen, J., Pedersen, M.T., Johansen, J.V., Cloos, P.A.,
Rappsilber, J., and Helin, K. (2011). TET1 and hydroxymethylcytosine in tran-
scription and DNA methylation fidelity. Nature 473, 343–348.
Wossidlo, M., Nakamura, T., Lepikhov, K., Marques, C.J., Zakhartchenko, V.,
Boiani, M., Arand, J., Nakano, T., Reik, W., and Walter, J. (2011). 5-Hydroxy-
methylcytosine in the mammalian zygote is linked with epigenetic reprogram-
ming. Nat. Commun. 2, 241.
Wu, S.C., and Zhang, Y. (2010). Active DNA demethylation: many roads lead to
Rome. Nat. Rev. Mol. Cell Biol. 11, 607–620.
Wu, H., and Zhang, Y. (2011a). Mechanisms and functions of Tet protein-medi-
ated 5-methylcytosine oxidation. Genes Dev. 25, 2436–2452.
Wu, H., and Zhang, Y. (2011b). Tet1 and 5-hydroxymethylation: a genome-
wide view in mouse embryonic stem cells. Cell Cycle 10, 2428–2436.
Wu, H., Coskun, V., Tao, J., Xie, W., Ge, W., Yoshikawa, K., Li, E., Zhang, Y.,
and Sun, Y.E. (2010). Dnmt3a-dependent nonpromoter DNAmethylation facil-
itates transcription of neurogenic genes. Science 329, 444–448.
Wu, H., D’Alessio, A.C., Ito, S., Wang, Z., Cui, K., Zhao, K., Sun, Y.E., and
Zhang, Y. (2011a). Genome-wide analysis of 5-hydroxymethylcytosine distri-
bution reveals its dual function in transcriptional regulation in mouse embry-
onic stem cells. Genes Dev. 25, 679–684.
Wu, H., D’Alessio, A.C., Ito, S., Xia, K., Wang, Z., Cui, K., Zhao, K., Sun, Y.E.,
and Zhang, Y. (2011b). Dual functions of Tet1 in transcriptional regulation in
mouse embryonic stem cells. Nature 473, 389–393.
Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu,
Y., et al. (2012). Inhibition of a-KG-dependent histone and DNA demethylases
by fumarate and succinate that are accumulated in mutations of FH and SDH
tumor suppressors. Genes Dev. 26, 1326–1338.
Xie, W., Barr, C.L., Kim, A., Yue, F., Lee, A.Y., Eubanks, J., Dempster, E.L., and
Ren, B. (2012). Base-resolution analyses of sequence and parent-of-origin
dependent DNA methylation in the mouse genome. Cell 148, 816–831.
Xu,W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.H., Ito, S., Yang, C.,Wang,
P., Xiao, M.T., et al. (2011a). Oncometabolite 2-hydroxyglutarate is a compet-
itive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19,
17–30.
Xu, Y., Wu, F., Tan, L., Kong, L., Xiong, L., Deng, J., Barbera, A.J., Zheng, L.,
Zhang, H., Huang, S., et al. (2011b). Genome-wide regulation of 5hmC, 5mC,
and gene expression by Tet1 hydroxylase inmouse embryonic stem cells. Mol.
Cell 42, 451–464.
Xu, Y., Xu, C., Kato, A., Tempel, W., Abreu, J.G., Bian, C., Hu, Y., Hu, D., Zhao,
B., Cerovina, T., et al. (2012). Tet3 CXXC domain and dioxygenase activity
cooperatively regulate key genes for Xenopus eye and neural development.
Cell 151, 1200–1213.
Yamaguchi, S., Hong, K., Liu, R., Shen, L., Inoue, A., Diep, D., Zhang, K., and
Zhang, Y. (2012). Tet1 controls meiosis by regulating meiotic gene expression.
Nature 492, 443–447.
Yamaguchi, S., Shen, L., Liu, Y., Sendler, D., and Zhang, Y. (2013). Role of Tet1
in erasure of genomic imprinting. Nature 504, 460–464.
Yamaji, M., Ueda, J., Hayashi, K., Ohta, H., Yabuta, Y., Kurimoto, K., Nakato,
R., Yamada, Y., Shirahige, K., and Saitou, M. (2013). PRDM14 ensures naive
pluripotency through dual regulation of signaling and epigenetic pathways in
mouse embryonic stem cells. Cell Stem Cell 12, 368–382.
Yang, H., Liu, Y., Bai, F., Zhang, J.Y., Ma, S.H., Liu, J., Xu, Z.D., Zhu, H.G.,
Ling, Z.Q., Ye, D., et al. (2013). Tumor development is associated with
decrease of TET gene expression and 5-methylcytosine hydroxylation. Onco-
gene 32, 663–669.
Yildirim, O., Li, R., Hung, J.H., Chen, P.B., Dong, X., Ee, L.S., Weng, Z., Rando,
O.J., and Fazzio, T.G. (2011). Mbd3/NURD complex regulates expression of
5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell 147,
1498–1510.Cell 156, January 16, 2014 ª2014 Elsevier Inc. 67
Yin, R., Mao, S.-Q., Zhao, B., Chong, Z., Yang, Y., Zhao, C., Zhang, D., Huang,
H., Gao, J., Li, Z., et al. (2013). Ascorbic acid enhances Tet-mediated 5-meth-
ylcytosine oxidation and promotes DNA demethylation in mammals. J. Am.
Chem. Soc. 135, 10396–10403.
Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J.,
Cohen, P., and Smith, A. (2008). The ground state of embryonic stem cell
self-renewal. Nature 453, 519–523.
Yu, M., Hon, G.C., Szulwach, K.E., Song, C.X., Zhang, L., Kim, A., Li, X., Dai,
Q., Shen, Y., Park, B., et al. (2012). Base-resolution analysis of 5-hydroxyme-
thylcytosine in the mammalian genome. Cell 149, 1368–1380.
Zhang, H., Zhang, X., Clark, E., Mulcahey, M., Huang, S., and Shi, Y.G.
(2010). TET1 is a DNA-binding protein that modulates DNA methylation
and gene transcription via hydroxylation of 5-methylcytosine. Cell Res. 20,
1390–1393.
Zhang, L., Lu, X., Lu, J., Liang, H., Dai, Q., Xu, G.L., Luo, C., Jiang, H., and He,
C. (2012). Thymine DNA glycosylase specifically recognizes 5-carboxylcyto-
sine-modified DNA. Nat. Chem. Biol. 8, 328–330.68 Cell 156, January 16, 2014 ª2014 Elsevier Inc.Zhang, R.R., Cui, Q.Y., Murai, K., Lim, Y.C., Smith, Z.D., Jin, S., Ye, P., Rosa,
L., Lee, Y.K., Wu, H.P., et al. (2013). Tet1 regulates adult hippocampal neuro-
genesis and cognition. Cell Stem Cell 13, 237–245.
Zhu, J.K. (2009). Active DNA demethylation mediated by DNA glycosylases.
Annu. Rev. Genet. 43, 143–166.
Zhu, B., Zheng, Y., Hess, D., Angliker, H., Schwarz, S., Siegmann,M., Thiry, S.,
and Jost, J.P. (2000). 5-methylcytosine-DNA glycosylase activity is present in
a cloned G/T mismatch DNA glycosylase associated with the chicken embryo
DNA demethylation complex. Proc. Natl. Acad. Sci. USA 97, 5135–5139.
Zilberman, D., Coleman-Derr, D., Ballinger, T., and Henikoff, S. (2008). Histone
H2A.Z and DNA methylation are mutually antagonistic chromatin marks.
Nature 456, 125–129.
Ziller, M.J., Gu, H., Mu¨ller, F., Donaghey, J., Tsai, L.T., Kohlbacher, O., De
Jager, P.L., Rosen, E.D., Bennett, D.A., Bernstein, B.E., et al. (2013). Charting
a dynamic DNA methylation landscape of the human genome. Nature 500,
477–481.
